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RIASSUNTO 
 
La subunità CK2α contiene quattro motivi prolina diretti, localizzati al C-
terminale, che sono fosforilati dalla Chinasi Ciclina Dipendente 1 (Cdk1). 
Queste fosforilazioni sono molto importanti per la regolazione di CK2, 
infatti, le cellule transientemente transfettate con un costrutto che mima 
costitutivamente la fosforilazione CK2αT344E/T360E/S362E/S370E 
(CK2α4E) mostrano come fenotipo una mitosi aberrante. I nostri dati 
confermano l'implicazione di CK2 nella regolazione mitotica e definiscono 
un preciso ruolo per CK2α fosforilata; infatti il mutante fosfo-mimetico 
CK2α4E è in grado di fosforilare in maniera preferenziale alcuni substrati. 
Uno di questi è la istone Demetilasi Lisina Specifica 1 (LSD1). 
LSD1 è un importante attore dell'epigenetica. Esso reprime o attiva la 
trascrizione del gene bersaglio mediante la rimozione di gruppi metile dalla 
Lisina 4 o 9 dell'istone H3. La fosforilazione di LSD1 ricombinante umana è 
stata confermata in vitro e le costanti cinetiche sono state determinate. 
Tramite analisi di spettrometria di massa sono stati identificati i residui 
fosforilati: Serina131, Serina137 e Serina166. Tutti i fosfositi appartengono 
alla regione N-terminale di LSD1 (1-178), che non è osservabile nella 
struttura cristallografica (AOD 179-852) e che è già stata ipotizzata come 
regione regolatoria. Un'analisi bioinformatica del tipo "molecular modeling" 
suggerisce questa regione come metastabile ed evidenzia che la Ser131, 
Ser137 e la Ser166 sono esposte al solvente. Per confermare l'esistenza di 
un'interazione funzionale tra CK2 e LSD1 sono stati generati due vettori di 
transfezione (pTP6-Ko/Flag-LSD1), uno con la mutazione fosfo-difettiva 
Ser131Ala e l'altro con la mutazione fosfo-mimetica Ser131Glu. Questi 
costrutti hanno permesso di confermare il ruolo chiave esercitato dalla 
fosforilazione di LSD1 in cellule. 
Mediante la tecnica "quantitative Real time PCR" alcuni mRNA modulati 
comunemente da LSD1 sono stati determinati, e dati riguardo l'attività dei 
mutanti di LSD1 sono stati raccolti. In particolare, la quantità di mRNA del 
fattore di trascrizione FoxA2 era ridotta dal mutante Ser131Glu, ma risultava 
inalterata in cellule che esprimevano il mutante Ser131Ala, in accordo con 
l'ipotesi che esista una relazione tra la fosforilazione della Ser131 e la 
trascrizione di FoxA2.    
Inoltre, la transfezione di LSD1 "Flaggata" ha permesso di eseguire 
l'immunoprecipitazione del complesso di LSD1 in cellule HEK293T. Questa 
procedura ha dimostrato che CK2α è un interattore di LSD1 in cellule; 
inoltre effettuando un saggio chinasico con [γ-33P]ATP sul campione 
immunoprecipitato, e' stata rilevata la fosforilazione di LSD1 da parte di una 
chinasi presente nell'immunocomplesso. L'inibitore specifico di CK2, 
CX4945 (30 nM) riduceva la fosforilazione di LSD1 e confermava che CK2 
è la chinasi responsabile di questo evento. 
 
 
ABSTRACT 
 
CK2α subunit contains four proline-directed phosphorylation sites on its 
C-terminal tail, which are phosphorylated in cell progressing through 
normal mitosis by Cyclin dependent kinase 1 (Cdk1). These 
phosphorylations play an important role in the regulation of CK2, 
considering that cell with transient expression of phospho-mimic mutant 
CK2αT344E/T360E/S362E/S370E (CK2α4E) show a defective mitosis. 
Our data confirm the implication of CK2 in the mitotic regulation and 
disclose a precise role for the phosphorylated CK2α; indeed the phospho-
mimic mutant CK2α4E preferentially phosphorylates few endogenous 
substrates in comparison to wild type. One of these is the Lysine Specific 
histone Demethylase 1 (LSD1). 
LSD1, an important player of the epigenetic machinery, can either repress 
or activate target genes by catalyzing the demethylation at Lys4 or 9 of H3 
histone. Phosphorylation of human LSD1 by CK2 has been confirmed in 
vitro and the kinetic constants have been determined. Furthermore, mass 
spectrometry analysis revealed that LSD1 is phosphorylated at several 
sites, Ser131, Ser137 and Ser166, in its N-terminal domain. This region of 
LSD1 (1-178) is not crystallographically aviable, in contrast to the AOD 
domains (179-852) and it has been supposed to play a regulatory function. 
The molecular modeling of this region suggests a metastable 
conformational state with Ser131, Ser137 and Ser166 exposed to the 
solvent. To confirm the existence of this functional interaction between 
LSD1 and CK2 in vivo, two transfection vectors (pTP6-Ko/Flag-LSD1) 
have been generated, expressing mutants of LSD1, a phospho-defective 
and a phospho-mimic mutant, Ser131Ala and Ser131Glu respectively. 
These tools have been exploited to confirm the key-role of Ser131 
phosphorylation in the regulation of LSD1 in cells. The expressions of 
several known LSD1 affected mRNAs were detected by Quantitative Real 
time PCR, disclosing correlation between LSD1 mutation and its 
biological activity. In particular, mRNA level and also protein expression 
of the transcription factor FoxA2 were decreased by the LSD1 Ser131Glu 
mutant, but remained unaltered when LSD1 Ser131Ala mutant was 
expressed, consistent with a relationship between  Ser131 phosphorylation 
and FoxA2 transcription. Furthermore, the transfection of flagged LSD1 
allowed the immunoprecipitation of the LSD1 complex in HEK293T cells. 
Our data disclose that CK2α is an interactor of LSD1 in cells. Performing 
kinase assay with [γ-33P]ATP in IPs, the phosphorylation of LSD1 by a 
co-immunoprecipitated kinase was detected. The very specific CK2 
inhibitor CX-4945 reduced the phosphorylation of LSD1 in IPs, 
confirming that CK2 is the kinase responsible for this phosphorylation. 
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Introduction 
1. Protein kinases 
 
Protein phosphorylation is a common post-translational modification, and 
probably it involves about 50% of eukaryotic proteins, leading to a change in 
their own activities and biological functions.  
The enzymes responsible for the catalysis of this event are referred to protein 
kinases. 
Eukaryotes have more than 500 different protein kinases [1], each with 
specific substrates. This huge number of enzymes with a similar action 
reflects the importance of this modification and the specificity of signaling 
mediated by phosphorylation. In fact, many biochemical phenomena are 
finely tuned by phosphorylation (e.g. energy metabolism, transcription, cell 
survival, and cross-talk) [2].   
Many human diseases are related with the altered expression or abnormal 
function of kinases, thus kinases and their substrates are often important 
drugable targets. 
Protein kinases are enzymes able to catalyze the transfer of the terminal 
phosphate group (called γ-phosphate) of ATP and, more rarely, GTP to a 
nucleophilic residue. In principle all nucleophilic side chains could be 
phosphorylated, but some of them are not proved to be, and currently only 
serine, threonine, tyrosine and histidine appear the main players of this 
modification.  
Protein kinases family is a monophyletic group of enzymes originated by a 
single ancestor protein, with a conserved domain of approximately 300 
amino acids.  
This conserved string of residues invariably codifies for a quite conserved 
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pocket able to host the phospho-donor (ATP or/and GTP), called catalytic 
site, and a variable phosphor-acceptor substrate binding zone, solvent 
exposed. 
The modern classification of protein kinases family has been made by 
phylogenic comparison, allowing the identification of seven main groups 
(Fig. 1A) [3].  
I. AGC kinases 
Ser/Thr kinases with a basophilic consensus sequence. Member of this 
group are PKA and PKC. 
II. CAMK kinases  
Ser/Thr kinases regulated by Ca2+ /Calmodulin system. 
III. CMGC kinases  
A group including many proline direct kinases, such as CDKs and 
ERKs. CK2, the subject of this thesis is also part of the CMGC group. 
IV. and V.   TK and TKL kinases  
A very large group, counting for Tyr directed (TK) or dual specificity 
kinases (TKL).     
VI. STE kinases 
 Members of this cluster take part in the Mytogen Activated Pathways 
(MAP). 
VII. CK1 kinases 
Containing the “casein kinase I” subfamily. 
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As proposed in 1995 with the primary structure alignment of catalytic 
domains, it is possible to detect 12 typical “sub-domains” (I to XI and VI-b). 
There are only 12 “invariant” residues in protein kinases (Fig. 1B); most of 
them are implicated in the catalytic process and their substitutions are not 
allowed [3]. 
 
 
 
 
 
 
 Domain                                                                       I 
                                                                          <--------- 
CK2alfa1a[Hom]          ---------------MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKL 
AMP-Dep-KINASE-A        --------------------------------------------------MDQYEKVEKI 
CMGC                    MLETSGDDLPVPNKVINYRIIATSRVHAYISKYIYPSFLSYSEFGLSFGVLSKYRVNKII 
     
            ..*.  . : 
 
 
 
 
 
Fig.1A: 
Radial phylogenetic tree 
of the protein-kinases 
family 
 
By an unrooted phylogenetic 
tree, all the protein-kinases are 
reported. They form seven main 
groups.   
 
 
Fig. 1A 
 
Fig. 1B: 
Multi-alignment of kinases reveals the invariant residues. 
 
A multi-alignment of CK2α, AMPK, CMGC has been performed by clustalX2 software. The 
twelve typical sub-domains can be observed. Furthermore in the pictures the invariable 
residues essential for the kinase activity are remarked in black. 
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Domain                         I                  II              III           IV 
                      ------------->    <--------------------><--------> <---------- 
CK2alfa1a[Hom]        GRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADI 
AMP-Dep-KINASE-A      GEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHS-NIVKLQDV 
CMGC                  GFGKYSTVFMATNGK--KKVAIKVFKDV-----KEITIKREVFILKTCRKLSNIVQIIDV 
                      * *.*. *: * :    :.:.:* ::  ::         **: :*:  :   **: : *: 
 
Domain                    IV                 V                       VI-a       VI-b 
                        ----->    <-------------------->      <--------------> <----   
CK2alfa1a[Hom]          VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD-----IRFYMYEILKALDYCHSMGIMHR 
AMP-Dep-KINASE-A        VHS--EKRLYLVFEYLD-LDLKKHMDSTPDFSKDLHMIKTYLYQILRGIAYCHSHRVLHR 
CMGC                    VKDPKYNSISIVMEYCKASNAEILENLSLDDF------RIYIYQLINGLYNLHSHGIIHR 
                        *:.   .   :*:*: .  : :   :   *        : *:*:::..:   **  ::** 
 
Domain                    VI-b              VII            VIII                  IX    
                     ------------>   <----------------><--------------->       <---- 
CK2alfa1a[Hom]       DVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 
AMP-Dep-KINASE-A     DLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSHHYSTPVD 
CMGC                 DIKPENILYDKKTKQLKIGDLGLAEIY-FPLQQYTTGLGTLRWMAPELIFDYKFYDYAVD 
                     *:**.*:: *:. ..*:: * ***. :  * : :.  : :  : .**::.. : *. .:* 
 
Domain                    IX                                        X                          
                        ---------->             <------------------------------------ 
CK2alfa1a[Hom]          MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN-TELDPRFNDIL 
AMP-Dep-KINASE-A        IWSVGCIFAEMISQK-PLFPGDSEIDQLFKIFRIMGTP----YEDTWRGVTSLPDYKSAF 
CMGC                    MWAVGIILYVITIDYNKKNY-ETLGQMAIAVSEMLTPSEVLTFIDKYG-IFIPNSLLSAM 
                        :*::* ::  :          .   :  . : .:: .     : *.:          . : 
 
Domain                      X                          XI      
                        ---------->        <---------------------------------->  
CK2alfa1a[Hom]          GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQAR 
AMP-Dep-KINASE-A        PKWKPTDLETFVPN-----LDPDGVDLLSKMLLMDPTKRINARAALEHEYFKDLG----- 
CMGC                    PQVNFNMWPTYIEHMKPKFKDDDMIDLMRKLLVADPQRRLSAMEALEHPFFDKVPPEFKE 
                         : . .    ::        . : :*:: *:*  *   *:.*  *:** :*  :       
 
Domain      
 
 
CK2alfa1a[Hom]              MGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQ- 
AMP-Dep-KINASE-A          ----------------------------------------------GMP---------- 
CMGC                      INKKHKLKHSIMVR--------------------------------ANAIKNNIKKRNI 
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2. The protein kinase CK2  
 
CK2 is a pleiotropic Ser/Thr kinase with constitutive activity and more than 
three hundreds substrates are reported [4]. CK2 was the first of the protein 
kinase to be discovered, together CK1, in  1953 [5]. It catalyzes the 
phosphorylation of Ser/Thr residues, specified by an acidic consensus 
sequence and it is implicated in several important signaling pathways, such 
as "Wnt" or "Akt" cascades [6]. CK2 is commonly described in vivo as a 
tetramer (called holoenzyme) composed by two catalytic subunits (α) and 
two regulatory subunits (β). Although the catalytic α (or α’) subunits of CK2 
are constitutively active, β subunits stabilize the two catalytic subunits, and 
regulate their specific activity. Furthermore, the regulatory subunit β 
interferes with the recruitment of CK2 substrates, which can be classified by 
their preferential recognition either by CK2 tetramer (class 3 substrates), by 
the CK2 catalytic subunit (class 2 substrates), or by both of them (class 1 
substrates) [7]. 
The phylogenetic analysis of the kinases discloses the presence of several 
conserved blocks [3], which can correlated to specific function. CK2 has 
these invariable blocks and many features of CK2 can be explained by these 
subdomains.   
 
 The glycine rich loop: it is required for the binding of the phospho-
donor molecule. Notably, in CK2 the ATP binding site is able to 
recognize also the GTP [8].   
 N-terminus of CK2: this region is responsible for the constitutive 
activity of CK2, probably by "freezing" the activation loop in its open 
position to the consequently active conformation.  In fact Δ2-12 and 
Δ2-30 deletion mutants bring to an inactive catalytic subunit, even if 
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its activity can be partially recovered adding the regulatory subunit β 
[9]. 
 Basic Stretch: CK2 has a huge positive area constituted mainly by two 
structural motifs, the basic stretch of the α-helix C (Lys74-Arg80) and 
the amino acidic triplet (Arg191, Arg195 and Lys198) in the P+1 loop. 
These regions are fundamental during the recognition of the acidic 
consensus motif typical of CK2 substrates, in particular at the 
positions n+3 and n+1 [10]. This motif is peculiar for CK2, indeed in 
Cyclin Dependent Kinase 2 (Cdk2) the sequence of ~KKKKKIKR~ 
(CK2) is replaced by the PSTAIRE helix, a motif required for the 
regulation of all the Cdks and for the binding of their substrates [11]. 
 Catalytic loop: the Asp156 (called catalytic aspartate) is connected to 
Asn161 by a short sequence. It comprises Lys158 that shields the 
negative charge of phosphoryl group during the reaction and the 
His160, which appears fundamental for the binding of the second 
negative determinants (n+2) of the consensus motif [12]. 
 Activation loop: many kinases need the rearrangement of this 
subdomain by phosphorylation or by interacting protein to exert full 
activity. CK2 does not need this step for its full activity, thanks to its 
N-terminal domain. 
         
These regions define many features of CK2 and explain the molecular 
mechanism which favors the substrates with acidic residues near the 
phospho-acceptor site.  
To understand the correct consensus sequence, a library of short peptides 
(substrates) was synthesized [13]. The research disclosed that in general 
serines are preferred over the threonines as phospho-acceptor amino acid, 
while exceptionally tyrosine can be phosphorylated. Furthermore, the 
minimal consensus of a generic CK2 substrate has a negatively charged 
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residue after the phospho-acceptor site at the position n+3 (Fig. 2). 
 
 
 
           X-1 - S/T - X+1 - X+2 - D/E+3. 
 
 
 
 
Acidic determinants could be represented also by phosphorylated amino 
acids, generating hierarchical multi-phosphorylation events. Sometimes, the 
lacking of the preferred determinant at position n+3, CK2 can also 
phosphorylate sites specified by multiply negatively charged residues in the 
range n-4/+7. Furthermore, basic residues near the phospho-acceptor site and 
a proline at position n+1 negatively affect CK2 activity, while hydrophobic 
determinants are generally tolerated [14]. 
 
 
3. Druggability of CK2 
 
CK2 is implicated in many neurodegenerative and inflammatory, diseases as 
well as viral affections and several types of tumors. For this reason CK2 has 
been indicated as a potential target for antiviral and  antineoplastic drugs as 
well as for the treatment of neurodegenerative diseases; many ATP 
competitive inhibitors has been discovered until now with different chemical 
scaffolds (polyalogentated benzimidazole, cumarine, anthraquinones, 
flavones) [15, 16, 17, 18, 19].  
On the other hand, a peculiar feature of CK2 is its insensitivity to 
Fig. 2: 
Schematic representation of the 
minimum CK2 consensus sequence 
 
Five amino acidic residues are reported, the 
minimal consensus of a generic CK2 substrate 
has a negatively charged residue after the 
phospho-acceptor site at the position +3.   
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staurosporine, a promiscuous ATP-competitive inhibitor, due to the tight 
(narrow) pocket of CK2 respect to other kinases.  
 
 
4. Functions and biological relevance of CK2 
 
CK2 has more than three hundreds substrates reported, thus it is quite 
difficult to define a clear network of action for this enzyme. Generally, CK2 
interferes in many pathways, generating a pro-survival response. 
In normal cell, it exerts a crucial role in sustaining cell division and 
proliferation, but its deregulated activity is also strikingly dangerous. Indeed, 
CK2 is a common denominator of cancer cells as anti-apoptotic agent [6, 
20]. 
As previously explained, the mechanism of action/regulation of CK2 is quite 
enigmatic. In the next section, some roles played by CK2 in three 
exemplificative biochemical pathways have been summarized. 
 
 Wnt signaling. 
The Wnt signaling pathway plays a significant role during 
embryogenesis, but it also exerts a very important action during the 
development of tumors, increasing cell-survival and counteracting 
apoptosis [21]. The final effector of Wnt pathway is β-catenin, a 
transcription factor able to modulate some important proteins and 
survival molecules. 
When Wnt ligand is off, β-catenin is degraded and the pathway is 
interrupted. In contrast, the activation of the pathway by Wnt ligand 
blocks β-catenin degradation and allows the transcriptional 
modulation.   
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In addition to Wnt ligand, other mechanisms can modulate this 
pathway.  In cancer cell, CK2 can take over the regulation of the Wnt 
pathway, generating a constitutive pro-survival stimulation. Indeed, 
CK2 is able to stabilize β-catenin, rescuing it from degradation [22].  
Thus, stabilized β-catenin can move to the nucleus and mediate the 
stimulus.  
Furthermore, other events mediated by CK2 have a role in this 
pathway. In fact, CK2 phosphorylates β-catenin, and at the same time 
the factor Dishvelled (DVI) [23]. Phosphorylated DVI further 
implements the β-catenin stability. Hence, CK2 modulates Wnt 
signaling by synergistic effects. These mechanisms of up-regulation 
signaling are good examples of CK2 pro-pathologic action. CK2 
"elevation" in tumor cells drastically changes the Wnt network 
equilibrium by aberrant phosphorylation of many proteins, increasing 
the final effector of the pathway and by passing cellular check-points. 
       
 PI3K/Akt signaling. 
 
Akt is a very important protein kinase, involved in many cellular 
processes such as cell proliferation and development, and its activity is 
often increased in neoplastic cells, allowing the cellular abnormal 
proliferation.  
It is demonstrated that CK2 up-regulates Akt by the phosphorylation 
at the residues Ser129 [24].   
Furthermore, a synergistic effect able to up-regulate Akt pathway is 
carried out by the CK2 dependent phosphorylation of PTEN. Indeed, 
PTEN represses Akt by its catalytic action. Aberrant CK2 activity 
antagonizes PTEN and contributed to Akt hyper-activation [25].     
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 NF-κB signaling. 
NF-κB is a transcription factor able to modulate cell proliferation, 
apoptosis and immune response. Aberrant activation of NF-κB leads 
to tumorigenesis by deregulation of cell cycle and by resistance to 
apoptosis. NF-κB is normally present in the cytoplasm, associated 
with IκB to form an inactive complex. The activation of NF-κB occurs 
by IκB-kinase (IKK), which phosphorylates IκB. Phosphorylated IκB 
is prematurely degraded, and then NF-κB raises its expression level 
and enters the nucleus, modulating the expression of several genes.  
Also CK2 can phosphorylate IκB with the same effect of IKK [26], 
and furthermore CK2 can stabilize NF-κB by a directly 
phosphorylation [27].  
CK2 phosphorylations act in a synergic way to increase NF-kB 
signaling. 
 
These three examples suggest the presence of CK2 in a network of 
interaction involving many important pathways. Thus the definition “Master 
regulator kinase” has been already proposed for CK2 [28]. 
In the table 1, several examples of CK2 targets have been reported.  
 
 
 
 
 
 
 
 
-Introduction- 
 
  
       11 
 
  
 
 
 
 
Signaling proteins 
β-catenin, CDC-34, DARPP-32, 
Calmodulin, IRS-1, PP2Cα, PTEN, 
PKA RII, PKCIIβ. 
 
Transcription or translation factor 
and  DNA/RNA interacting proteins 
TFIIIB-TBP, RNA Polymerases, 
TFIIIA, NF-κB, IκBα, IκBβ, DNA 
topoisomerase IIα, P53 
Cytoskeleton and structural proteins β-tubulin and spectrin 
Metabolism enzymes 
Acetyl CoA carboxilase and 
Ornithine decarboxilase 
 
 
5. CK2 regulation: protein interaction, 
phosphorylation and the function of CK2α C-terminus 
 
While the role of CK2 is clear, the mechanism which regulates the action of 
this protein-kinase is still quite enigmatic. Unlike other kinases, there is no 
evidence concerning an activation domain in CK2, thus other form of 
regulation have been hypothesized, for example a proposed mechanism is 
the regulation of CK2 by interacting proteins.  
Consistent with this, many CK2 partners have been disclosed [29].  
Furthermore, the interaction of the C-terminus segment of CK2α with some 
proteins is essential for the correct localization of CK2, in fact, the precise 
cellular localization of CK2 during the spindle formation is dependent on the 
Tab.1:  
A selection of CK2 substrates in vivo [4]. 
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interacting protein peptidyl-prolyl cis/trans isomerase 1 (Pin1) [30] and on 
the phosphorylation of CK2α by the Cyclin dependent kinase1 (Cdk1) [30, 
31].  
Until 1995 the only feature disclosed about the C-terminus of CK2α was its 
instability, when the first observation of CK2 phosphorylation mediated by 
Cdk1 was published [31], raising interest on the C-terminal portion of CK2α 
and on the role that the phosphorylation of this domain could have on CK2 
regulation. 
Consistent with a regulation mediated by the C-terminal segment of CK2α, 
an isoform of CK2α commonly named as CK2α' has an alternative C-
terminal sequence. Indeed, in human there are two catalytic subunits: α (391 
AA) [NP_001886] and α' (350 AA) [NP_001887.1]. CK2α' and CK2α have 
high similarity within their catalytic domains, but CK2α' is by 40 amino 
acids shorter than CK2α. It can form a functional holoenzyme with CK2β 
(α'2β2), which is reported in vivo and represent the main form of CK2 in 
particular tissues such as testicles [32]. 
CK2α and CK2α' have similar sequences (75% identity) while they have 
different functions, indeed in knock-out mice the lacking of CK2α cannot be 
compensated by the presence of CK2α'. Indeed, the disruption of the gene 
coding for the catalytic subunit α causes a lethal phenotype in mus musculus 
[33], while the knock-out of CK2α' gene determines viable phenotype. 
Although mice lacking of CK2α' are viable, they have a defective 
spermatogenesis and males being sterile [34].  
Notably, CK2α' and CK2α are not present in all the organisms. For example, 
budding yeast but also plants and insects do not have the α' isoform, 
suggesting that in lower eukaryotes just a single CK2α isoform is required. 
In 2009, the role of the C-terminal phosphorylation of CK2α was correlated 
to the mitosis [35], and more recently, it was reported that CK2α residues 
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Thrp 344, Thrp 360, Serp362 and Serp370 act as bait for peptidyl-prolyl 
cis/trans isomerase 1 (Pin1) in vitro and in vivo [36]. Furthermore the 
authors observed the complete segregation of CK2α mediated by Pin1 within 
the chromosomes to form mitotic spindle.   
Interesting clues were provided by the experiment where the effects of the 
transient expression of phospho-mimicking CK2α mutant T344E-T360E-
S362E-S370E (CK2α 4E) and of a not phosphorylable CK2α mutant T344A-
T360A-S362A-S370A (CK2α 4A) were compared [35]. When CK2α4E 
promoter was activated, cells showed a defective reproduction with 
unbalanced chromosomic segregation and aberrant amplification of the 
centrosomes.  
Taken together, these observations suggest that proper temporal regulation of 
CK2α phosphorylation is required for correct mitotic progression and 
highlight a role of CK2α C-terminal phosphorylation in the maintenance of 
spindle integrity and control of cell division [36].  
In summary, CK2α C-terminus is related to mitotic events. The preferential 
expression of the CK2α’ in tissue undergoing meiosis (e.g. testis) [32] is 
consistent with the hypothesis that CK2α' is important in cells having 
unconventional cell cycle (e.g. meiotic cell cycle and G0 quiescence). 
Notably, mice lacking CK2α’ undergo defective spermatogenesis, which 
generates gametes with unbalanced epigenetic marks [34]. This data supports 
the view that CK2 is also involved in the epigenetic regulation. 
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6. CK2 is a player of the ATP-dependent 
chromatin-remodeling and histone-deacetylase activities 
complex NuRD 
 
CK2 is abundant in the nucleus and it participates in many complexes, one of 
these is related to chromatin modification: the ATP-dependent chromatin-
remodeling and histone-deacetylase activities complex (NuRD). This is a 
macro molecular aggregation of proteins, displaying both histone 
deacetylase and ATPase activities. It negatively modulates the transcription 
of the genes by removing acetyl groups bound to lysines of the histone 
proteins H3 and H4. This event generates a more stable interaction between 
DNA and nucleosome, blocking the recruitment of the RNA polymerase II. 
CK2 is described as a player of this complex, exerting a fundamental role in 
its regulation in vivo [29]. Moreover, the treatment with CK2 inhibitors 
modulates NuRD complex activity suggesting that CK2 is related to the 
epigenetic machinery [37]. Increased binding of the transcriptional factor 
SDS3 to the promoter region after inhibition of CK2 further confirms this 
hypothesis in vivo [38]. CK2 is related in epigenetic at many levels. 
Transcriptional factors and HDAC2 are substrates of CK2, suggesting an 
important role mediated by CK2 in chromatin remodeling and quality control 
of gene transcription.  
 
7. Histone proteins can control the genetic 
information  
 
DNA is the most famous player of the genome, although it is not sufficient 
to store genetic information; indeed the basic unit of the chromatin is formed 
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by DNA and proteins. These units are termed “nucleosomes” (Fig. 3A)  [39] 
and are the major components of chromatin and chromosomes. 
Each nucleosome consists of an octameric particle of histone proteins (H2A, 
H2B, H3, H4 and their natural variants) that binds and wraps 146 base pairs 
of DNA  (Fig. 3B) [40]. 
These structures represent a dynamic system in turbulent evolution. Hence 
chromatin fluctuates between its condensate form and its elongated form like 
a spring. Packaging of chromatin plays two fundamental roles: it preserves 
DNA from damage and prevents binding of effector proteins to DNA. 
A proper management of condensation makes possible specific genetic 
programs instead of a random reading of the DNA.  
Chromatin condensation regulates gene expression, cell proliferation, 
chromosome segregation and other essential events. 
The histone protein modifications are essential signals for the cell, 
modulation of all these events. To note that, chromatin modulation is 
governed by covalent marks hitting the histone proteins and not directly 
DNA.  
Consistent with this, a great amount of residues of histones are located in 
unfolded regions; N-terminal and C-terminal tails of histone proteins 
protrude from the nucleosomal surface, where they can be affected by 
numerous post-translational modifications (Fig. 4).  
 
 
 
 
 
 
 
-Introduction- 
 
  
       16 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histones (especially H3 and H4) can be specifically modified by a set of 
enzymes: 
1. Protein kinases and protein phosphatases can add or remove 
Fig. 3A: 
Electron microscopy reveals 
the structure of the chromatin 
[40] 
 
Chromatin appears as a chain of 
beads. Each bead is a nucleosome, a 
particles formed by proteins and DNA.    
Fig. 4 
Schematic representation of a 
nucleosome and its possible 
modifications 
 
 N-terminal and C-terminal segments 
of the histone proteins (H2A, H2B, H3 
and H4) protrude from the surface 
and become the target of many 
enzymes. About twenty modifications 
have been reported, and each of these 
has a biological effect.         
 
Fig. 3B: 
Schematic representation of  
the crystallographic structure of 
nucleosomes and DNA  
 
 DNA and nucleosome form an ordered structure and 
each nucleosome binds 146 bp of DNA. 
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phosphates to serines and threonines. 
2. Lysine methyl-transferases (HMTs), lysine demethylases (HDMs), 
lysine acetyl-transferases (HATs) and lysine deacetylases (HDACs) 
can modify the nucleosomes, creating methyl and acetyl docking sites.  
3. Also other events can happen such as lysine ubiquitination, lysine 
biotinylation, lysine sumoylation, arginine methylation, glutamic acid 
ADP-ribosylation, and furthermore glutamic acid δ-polimerization.   
All these modifications together generate a whole signal (sum of many 
messengers), modulating the genome reading, and furthermore all the events 
occurred to chromatin. 
Indeed, histone post-translational modifications allow DNA-Histone 
stabilization and destabilization, but also the recruitment of specific protein 
complexes [41].   
Histones are a remarkable example of combinatorial and hierarchical 
regulation. Many stimuli converge into a global signal, which defines the 
chromatin region responsible for a specific biological function, suggesting 
how to process the genetic code. 
Without histone modifications an essential counterpart of the genetic code 
would lost; the genetic code would becomes cryptic and equivocal by the 
lacking of "reading schemes". 
On the other hand, DNA can be decrypted simply by the analysis of histone 
modifications, for example defining coding sequence and non-coding region 
[42, 43].   
 
7A. Histone acetylation 
Acetylations of histones have a positive effect on the transcription, 
preventing a stable interaction between DNA and chromatin scaffold (e.g. 
histones and other proteins). This allows at transcription factors to gain 
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access to promoters region, leading to the transcription of the genetic code in 
mRNAs, and then to the translation into proteins [44, 45]. 
The acetyl groups are bound to lysines present on the histone tails of H3 and 
H4 by histone acetyltransferases (HATs), using Acetyl-CoA as donor [41].  
Acetylation neutralize the positive charge of the lysine, preventing its 
interaction with the negative charge of the DNA by a merely electrostatic 
mechanism. 
Acetylations can be quickly reverted in a dynamic process, repressing or 
allowing gene transcription. 
To ensure a fine regulation of acetylations, specific enzymes are required. 
The units responsible for removing acetyl groups from lysines are called 
histone deacetylases (HDACs). Notably, HDACs and HATs can be found in 
the same complex, in conjunction with other enzymes able to modify 
histones [46], but even now, the modulation of these multi-protein 
complexes with many catalytic functions is quite enigmatic. 
 
7B. Histone methylation 
Histone methylation occurs both at lysines, where the amino group of the 
side chain become methylated, and at arginines, where methyl groups are 
covalently bound to the guanidinium group. 
Lysines are methylated by histone methyltransferases (HMTs), while 
arginines by protein arginine methyltransferases (PRMTs) [47]. PRMTs and 
HMTs are strictly site specific and act on distinct arginine and lysine 
residues. Methyl groups have specific functions and specific regulatory 
pathways, controlling these signals 
Methyl lysines could be mono-, di-, tri- methylated and the saturation of the 
individual residue is also finely tuned by many enzymes, suggesting specific 
functions for each variably methylated form. 
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7C. Methylation of histones has specific features distinguishing this 
epigenetic mark from acetylation 
 
Methylations of histone proteins do not neutralize the charge of lysine and 
arginine residues, thus do not significantly affect the interaction between 
DNA and the histone proteins. In contrast, methylated residues become 
binding sites for specialized domain able to recognize the methylated histone 
tails: Chromo-domain and Tudor-domain are two examples of these binding 
partners of methylated lysines [44, 48]. 
The specificity of an interactor for a single modification distinguishes the 
biological functions associated to each modified residues (e.g. H3K4me3 vs. 
H3K9me3). Unfortunately, the large amount of residues undergoing 
methylation impedes the understanding of the role of each individual 
modification.  
Another element, which distinguishes methylation and acetylation, is the half 
life of the mark. For a long time, histone methylation was considered to be a 
stable mark and no lysine specific demethylases were known. Thus lysine 
methylation was thought to be a signal responsible for the propagation of 
epigenetic information over many generations and it was thought that un-
methylated lysine were generated only by neo-synthesis. 
This view has been corrected and put in a new perspective by the recent 
identification of several demethylases [49, 50]. However, the half-life of 
histone methylation is significantly longer in comparison to other post-
translational modifications (e.g. acetylation) [51]. 
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8. Functions of methylated sites 
 
Histone methylation sites generate a wide pool of different biological 
signals; however it is difficult to assign a precise function for each 
modification. 
Below are reported several examples with known function of modifications 
involving histone H3. 
 
 H3K9me1 (Histone protein H3, lysine 9, mono-methylated) is 
generated by specific methyltransferases [52] and it is enriched in the 
promoter and 5' UTR with decreasing levels in coding regions of 
active genes and minimal enrichment in non-genic regions [53, 54]. 
This sharply contrasts with H3K9me3, which is found in non-genic 
regions, repressed promoters and coding regions of some inactive 
genes [55].  
 
 H3K9me2 domains are strongly correlated with binding of Lamin B1. 
Mapping of Lamin B1 interacting domains demonstrates that inactive 
genes are preferentially located at the nuclear periphery in association 
with the nuclear lamina [56]. The genomic blocks associated with the 
lamina change during differentiation, underscoring the dynamics of 
the interaction. The Lamin B1 associated regions are depleted of 
H3K4me3 and RNA polymerase II [56]. Taken together, these data 
suggest that H3K9me2 domains are critical determinants of higher 
order chromosome structure and nuclear architecture. 
 
  H3K9me3 has been thought to occur at heterochromatin regions and 
at repressed promoters. Indeed, studies concerning specific genes or 
-Introduction- 
 
  
       21 
 
  
 
looking at the entire genome have clearly demonstrated that this 
modification is connected to non-coding regions [57, 58]; however the 
exact role that this mark performs on coding regions is still unknown 
and it also emphasizes the necessity to better understand the 
importance of its localization. 
Interestingly, H3K9me3 is depleted at telomeres, but not at sub-
telomeric regions, suggesting that telomeres and subtelomeric regions 
are structurally distinct and different from other non-genic regions.  
One might speculate that the combined localization and activity of 
KMTs and KDMs are responsible for establishing, maintaining and 
restricting these domains [55]. Furthermore an additional speculation 
might be related to requirement of a more specific tuning of KDMs 
and KMTs by other signaling pathways (e.g. protein-kinases and 
phosphatases), generating additional steps in this regulation.  
 
  H3K4me3 signal typically shows peak levels at the 5′ UTR of 
actively transcribed genes [59], and shows strong positive correlations 
with transcription rates, activated RNA polymerase II occupancy, and 
histone acetylation levels [60]. The H3K4me3 marks function as the 
exclusive docking signal for plant homeo domain (PHD) finger 
proteins and other proteins involved in the recruitment of chromatin 
remodeling complexes, thus providing its own layer of transcriptional 
regulation [60, 61]. Consistent with this, the H3K4me3 signal is 
extremely weak, or even non-detectable, at regulatory sequences of 
the β-globin genes and other loci that remain silent in Central Nervous 
System (CNS) cells [62, 63, 64].  
 
 H3K4me2: In yeast, the role of H3K4me2 is related to the early 
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transcription process acting in concern to histones deacetylation [65]. 
If H3K4me2 plays a central role in transcription initiation, it will be of 
great interest to understand whether H3K4me2 is the subsequent result 
of H3K4me3 demethylation or to the addiction of methyl groups to 
H3K4 and H3K4me1.  
Understanding this regulation will provide fundamental insights on 
how promoter fidelity is dynamically controlled. 
Furthermore, the recent discovery of cryptic transcript emerging from 
bidirectional promoters in budding yeast and mammalian cells 
generates the question whether directional deposition of H3K4me2 
also plays a role in controlling transcriptional orientation when a 
promoter is activated [66]. Indeed, it is interesting to observe that 
H3K4me3 deposition overlap with the promoter, while H3K4me2 
encompasses the promoter region and the early coding sequence, 
suggesting a role in the ORF orientation (Fig. 5). A useful 
complement to the "opening" marks (H3K4me3 and me2) is provided 
by tri- and di-methylated forms of histone H3 lysines 9 and 27 [67], 
which define inactive or repressed gene and promoters.  
     
  Fig. 5: 
Representation of the gene Var of Saccharomyces Cerevisiae, during the 
transcription and the silencing [68]. 
 
 
 
 
 
 
 
 
 
 
Methyl marks define the fate of the gene. 
Tri-methylated H3K9 represses the 
transcription, while Lys4 methylations 
enhance the activity of the promoter. 
Furthermore, directionality of the 
H3K4me2 and H3K4me3 deposition 
might suggest to the RNA Pol II the 
position of the gene respect to the 
position of the promoter.        
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The distinction between H3K4me2 and H3K4me3 remains difficult 
but H3K4me3 is one of the most significant modifications present at 
the subtelomeric regions in human CD4+ T cells supposed to be 
transcriptionally silent [66]. 
In summary, H3K4me2 is present only in euchromatin, while 
H3K4me3 is present in euchromatin and subtelomeric regions, thus 
H3K4me2 and me3 usually carry signal “active transcription” but also 
other messages, probably in concert to acetylation and methylation at 
other residues. 
The additional findings of complexes able to modify many residues of 
the histone proteins suggest that a single action modulates at the same 
time Lys4, Lys9 and Lys27 methylation. This conclusion is further 
confirmed by the recent discovery of the Lysine Specific histone 
Demethylase 1, the first H3K4 demethylase identified [49]. 
Remarkably, LSD1 can also demethylate H3K9me2 and H3K9me1. 
Although the regulation of this ability remains unclear, unique 
mechanism able to modulate alone the methylated Lys4 and Lys9, 
which are opposite in functions, seems predictable [72].   
Furthermore, the action played by LSD1 during the mitosis and the 
finding of its hyperphosphorylation, might link CK2 and LSD1, 
opening new insight in LSD1 regulation. The observations that LSD1 
overexpression leads to unbalanced chromosomic segregation [69] and 
that unbalanced levels of di-methylated lysine 4 on Histone H3 
generates aberrant chromosomes segregation [70], further suggests a 
relation with CK2. Thus the phosphorylation of LSD1 could be a 
rational explanation of the Lys4 and Lys9 demethylase activity of just 
a single enzyme.  
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9. Lysine Specific histone Demethylase 1 (LSD1) 
 
LSD1 is a lysine specific histone demethylase, belonging to the FAD-
dependent amine oxidase super-family, which uses folate as final acceptor of 
the removed methyl group. 
 LSD1 is an enzyme of 94 KDa, consisting of an N-terminal SWIRM domain 
and a C-terminal amine oxidase domain (AOD). The active site cavity of 
LSD1 is located within the AOD and comprises about 50 invariants residues, 
creating a substantially larger catalytic pocket in comparison to other FAD-
dependent amine oxidases. The stable inhibition of LSD1 through FAD 
dependent cross-linker permits to understand the structure of LSD1 bound to 
an H3 peptide by crystallization [49], providing structural evidence for the 
reaction mechanism by which LSD1 demethylates H3K4. The crystal 
structure reveals electron density corresponding to the first seven residues of 
the 21-aminoacid peptide; the 2–6 residues of H3 adopt three consecutive γ-
turns assuming an unusual serpentine shape that fits tightly into the active 
site, forming numerous sequence-specific interactions with LSD1. The 
structure also suggests how the ε-N-methylamine moiety of H3K4 would 
protrude against the isoalloxazine ring of FAD in the context of a productive 
enzyme–substrate complex, while it shows that the N-terminus of H3 
engages a small anionic pocket present in the active site [49]. This suggests 
that the specificity of LSD1 for preferential H3K4 methylation arises from 
the stringent steric constraint that allows three residues of the N terminal 
segment of the histone protein H3 to fit within the enzyme pocket. 
Interestingly, the substrate specificity of LSD1 can be modulated by 
association with different regulatory proteins. For example, Metzger and 
colleagues disclosed that LSD1 can work as an H3K9 demethylase in the 
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presence of the androgen receptor (AR) [72]. The mechanism of this change 
in specificity remained elusive until the discovery that, during AR-dependent 
transcription, the phosphorylation of H3 at threonine 6 by PKCb1 prevents 
LSD1 from demethylating H3K4 due to steric constrains [73]; however how 
methylated H3K9 can fit in the same catalytic site as H3K4 remains elusive.  
Anyway, the crystallographic data provided a clear-cut explanation for why 
phosphorylation of histone H3T6 by PKCb1 leads to the inaccessibility of 
methylated H3K4 to the enzyme [72, 73, 74]. 
Concerning Lys4 and Lys9 demethylation, it may be surprising the lack of a 
second enzyme responsible for those two signals. In particular, the cross-talk 
between these two post-translational modifications (Lys4 and Lys9) 
catalyzed by a single enzyme appears paradoxal, because these residues have 
apparently opposite physiological functions. In fact, Lysine 4 is generally 
related to active transcription, while Lysine 9 is generally related to gene 
repression. 
These controversial aspects suggest that LSD1 may display antagonistic 
functions, and its regulation may influence the recognition of Lys4 or Lys9.   
This regulatory effect could lead to use one enzyme to regulate two opposite 
signals. Consistent with this, where H3K4me3, me2 and me1 stimuli are 
strong H3K9me3, me2 and me1 are weak. 
Remarkably, LSD1 is found in the HDAC containing CoREST complex [75, 
76, 77], suggesting that this complex may represent a global system able to 
modulate methylation and acetylation at the same time. 
Indeed, HDAC inhibition enhances histone acetylation but also increases 
Lys4 methylation [75]. 
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Current problems and aims of this thesis 
Until 1995 the only feature disclosed about the C-terminus of CK2α was its 
instability. The troubles encountered to obtain the full length form of CK2 
prevented for a long time the understanding of the function of the C-
terminal.  
In the 1995 the C-terminal phosphorylation of CK2α was reported and 
recently, a precise link between CK2 C-terminal sequence and chromosomes 
stability was discovered. 
These two findings are raising the interest on this domain of CK2α, 
suggesting that the C-terminal domain has regulatory function. 
Starting from these observations, we shed light on the role played by this 
domain of CK2α. 
In this thesis, we disclose several biological events occurring to the cells 
after the phosphorylation of the C-terminal segment of CK2α and describe a 
new signaling pathway related to the phosphorylation of the catalytic 
subunit.  
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Results and Discussion 
10. Phylogenic analysis of CK2α paralogous 
proteins 
 
CK2α and CK2β proteins have fundament functions and can be observed in 
all the species from Homo sapiens to plants and unicellular fungi.  
The CK2β is always observable in these organisms within a large amount of 
conserved residues.  
Also CK2α is invariably conserved in all species which have CK2β, 
suggesting the essential duality of these proteins.  
To note that, CK2α subunit can be coded by two genes in many species; two 
isoforms with homology and with a conserved catalytic domain. 
In human for example, the catalytic subunit α of CK2 is represented by two 
different genes: CK2α is placed on chromosome 20 and CK2α' is placed on 
chromosome 1. 
The catalytic domain of CK2α' is almost identical to CK2α, having similar 
catalytic function. The main difference is found in the two C-terminal 
domains, unrelated to each other. 
This particular evolution of CK2α and CK2α' suggests divergent functions 
due to the C-terminus. This conclusion is also supported by tissue specific 
expression of CK2α' (e.g. testicles) [32]. A third catalytic subunit of CK2 
was annotated in databank as CK2α'', a splicing variant of CK2α detected in 
neoplastic cell line Huh7 [78]. Notably, CK2α'' has an almost identical 
sequence to CK2α from amino acids 1 to 353, but after amino acid 353 
protein sequences are totally different. 
These three isoforms of CK2α are compatible with two hypotheses about 
their evolution: 
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Hypothesis 1: The C-terminal sequence of CK2α has not a 
physiological function, thus the evolution can act on it without any 
selection. These three sequences could diverge during the evolution, in 
contrast to the catalytic domains, which have a much stronger constrain 
and are almost identical in three isoforms.  
 
Hypothesis 2:  The C-terminal domains of the three CK2α subunits 
have distinct roles. They can respond to specific messengers and 
signaling pathways, acting as regulators and modulating the CK2 
activity in vivo by a still unknown mechanism. Owing to this, CK2α, 
CK2α' and CK2α" are isoforms having their own biological functions. 
 
The neighbor joining phylogenetic tree (Fig. 6A) formed by nineteen  
proteins "representative" of almost all the species belonging to the CK2α 
family, suggests that the three C-terminal segments of the catalytic subunits 
have functions and discards the idea of random evolution in this portions of 
the proteins. 
Indeed "human like" CK2α C-terminus is significantly conserved in CK2α 
proteins of all vertebrates (subclade 1). Hence, a strong selection plays 
against C-terminal mutated organisms, crystallizing the evolution of the 
sequence (Fig. 6A).  
Furthermore, in the phylogenetic tree, CK2α' forms a specific group 
(subclade 2). This data suggests a strong evolutive pressure, conserving the 
two isoforms with distinct biological functions. In fact, if CK2α and CK2α' 
have identical functions, the C-terminals of the two enzymes should be 
random and could not form specific subclades; moreover several organisms 
should lose these segments without functions.     
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The conclusion of distinct biological functions is consistent with the 
experiments of knock down of CK2α or CK2α' in mice, where they 
generates different phenotypes. 
 
 
 
 
 
 
 
 
 
 
0.1
CK2a Homo sapiens
CK2a Bos taurus
CK2a Mus musculus
CK2a Danio rerio
CK2a' Bos taurus
CK2a' Homo sapiens
CK2a' Rattus norvegicus
CK2a'Xenopus laevis
CK2a Apis linaeus
CK2a Camponotus vagus
CK2a Bombyx Mori
CK2a Daphnia magna
CK2a Ixodes affinis
CK2a Strongylocentrotus droebachiensis
CK2a caenorhabditis elegans
CK2a Drosophila willistoni
CK2a Zea Mais
CK2a Oryza Sativa
CK2a Arabidopsis thaliana
root
Development of the "human like"  
CK2α C-terminus 
Development of the isoform CK2α'  
Subclade (2)  
CK2α' 
(non 
phosphorylable)  
Subclade (1)  
"human like"  
CK2α C-terminus 
(phosphorylable)  
Fig. 6A: 
Phylogenetic tree of 19 CK2α sequences of different species.  
In the tree the evolutive history of the catalytic subunit CK2α is reported. The catalytic core is highly 
conserved from plant to human, while two minor subclades appear in vertebrates. CK2α in these species is 
represented by two isoforms in contrast to the other organisms (e.g. invertebrates have one isoform and a 
single gene). CK2α and CK2α' of vertebrates have additional segments located to the C-terminus, not 
present in insects, plants and fungi; CK2α of vertebrates has 57 conserved residues, while CK2α' has 16 
non-homologous residues.     
CK2α C-terminus is elongating 
Clade CK2α 
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The additional observation that ancestral organisms have shorter sequences 
(within the catalytic domain and without any form of C-terminus), discloses 
that "human like" C-terminal segment is not essential in the catalytic 
mechanism, but opens a new insight about a putative regulation in 
vertebrates. 
Taken together, these data support the hypothesis for the acquisition of a 
regulative function by this region, forming binding sites for interacting 
proteins and/or targeting CK2 towards favorable substrates. 
In fact, the C-terminal region of the human CK2α is phosphorylated during 
mitosis [31] and this event leads to a re-localization of CK2 in the nucleus 
[36], while CK2α' has not the phospho acceptor residues, and is not involved 
in mitotic events.  
As shown, many organisms have not this region and their CK2α cannot be 
phosphorylated (Fig.6B). The development of the "human like" CK2α C-
terminus generates the basis for a new form of regulation in human and in 
Fig. 6B: 
Multialignment of CK2α homologous sequences reveals that the phosphoresidues 
are developed later than the catalytic domain. 
In the multialignment the evolutive history of the protein CK2α is reported. The catalytic core is highly 
conserved from plant to human, while an additional segment located to the C-terminus can be observed in 
several organisms. The Cdk1 directed sites are located in this portion of CK2α, we can speculate that this 
domain has regulative functions, indeed the phylogenetic analysis suggests this portion of protein present 
only high evolved species, while simpler organisms don't have the phosphorylation sites.  
 
     
Catalytic domain                              C-terminus 
"Human like" C-terminus 
     (phosphorylable by Cdk1) 
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other vertebrates, but not in plant, fungi and invertebrates. 
To note that CK2α' has developed in organisms which have the 
phosphorylable CK2α, suggesting that a non-phosphorylable enzyme is 
essential for these organisms, besides the phosphorylable one. 
      
 Human isoforms of CK2 α 
Three isoforms of CK2α have been annotated in databanks: CK2α, CK2α', 
CK2α''. 
The main differences among the three isoforms are length and sequence of 
the C-terminal segment. This supports the hypothesis that this structural 
elements act as docking site for interactors.  
Consistent with this function, peptidyl-prolyl cis/trans isomerase 1 (PIN1) 
binds to CK2α through by its phosphoresidues located in the C-terminal 
segment [30, 36].  
In figure 7 are schematically represented the three isoforms to outline the 
main difference and the putative docking sites. 
 
 
 
 
Fig. 7: 
Schematic representation of the three isoforms of human CK2α  
 
In the picture, a similar catalytic 
core (AA 1-334) is linked to three 
alternative segments. Currently, no 
regulatory functions are 
associated to the C-terminal 
portion of CK2α, but the 
phosphorylation of α isoform and 
development of α' in vertebrates 
might sustain this hypothesis. The 
additional finding of the third 
isoform (α") discovered in neo-
plastic cells further supports this 
idea.     
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11. Possible role of CK2α C-terminal as regulator of 
the catalytic activity  
 
The specific activities of CK2α-wt, CK2α-4E and CK2α-Δ1-336, 
purified to homogeneity (supplementary materials S1), were determined 
using the synthetic peptide RRRADDSDDDDD as a phospho acceptor 
substrate. 
In table 2 and in figure 8, the means of the values of specific activities of 
the three forms of the catalytic subunits CK2α are reported. The mutants 
help to understand if the C-terminal segment plays a role during the 
catalysis. In particular the mutant CK2α-4E mimics the effect of the 
phosphorylation of CK2α, while the truncated form Δ1-336 gives 
information about the role of the whole C-terminal segment. 
Our data suggests that the mutant CK2α-Δ1-336 has a higher specific 
activity than CK2α-wt (p<0.05), reflecting a possible down-regulatory 
role of the C-terminal tail. 
In contrast, the specific activity of CK2α-4E (a mutant of CK2α able to 
mime the phosphorylation of the Thr344, Thr360, Ser362, and Ser370) is 
quite comparable to that of CK2α-wt.  
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Specific 
Activities 
CK2α-wt CK2α-4E CK2α-Δ1-336 
Mean 
(pmol/mg*min) 
587,4 (#) 710,8 1000,2 (#) 
Confidence  
(CF:95%) 
±157,2 ±135,1 ±188,8 
 
 
To sum up, the lack of the C-terminal segment of CK2α leads to a 
significant increase of CK2 activity. 
However, the presence of truncated forms (Δ1-336 or similar) have not 
been demonstrated in cell, thus our finding is interesting in term of 
structural and functional biology, but probably it is not related to any 
mechanism of regulation in vivo.  
The additional finding that CK2α-4E (mimicking the C-terminal tetra-
phosphorylation) has similar specific activity to CK2α-wt, suggests that 
CK2 activity is not modulated by the C-terminal phosphorylation. This 
data suggests that the real function of this segment of CK2α is related to 
other events.  
 
Tab. 2 and Fig. 8: 
Evaluation of the specific activity of CK2wt, CK2α-Δ1-336 (no C-terminus), 
CK2α-4E (phospho mimetic C-terminus). 
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12. Autophosphorylation of the catalytic subunits 
CK2α-wt, CK2α-4E and CK2α-Δ1-336 
 
Autophosphorylation of CK2α is often reported in the  literature, 
although no one has disclosed any clear function for this event.  
The autophosphorylation of the mutants CK2α-4E and CK2α-Δ1-336 in 
comparison to CK2α-wt was analyzed. The experiment shows an 
increased autophosphorylation of CK2α-4E in comparison to CK2α-wt. 
However, the autophosphorylation of the catalytic subunits (in absence 
to CK2β) is inhibited in presence of 50 and 100 mM NaCl (Fig. 9A), 
suggesting that the phosphorylation could be negligible in a 
physiological conditions.  
In the presence of CK2β, CK2α-4E auto-phosphorylation remains 
detectable up to 200 mM NaCl, while the other CK2α forms don't 
undergo autophosphorylation under these conditions. Thus, the 
autophosphorylation of CK2α-4E acquires a physiological relevance in 
presence of CK2β (Fig. 9B) and in presence of polycations 
(supplementary materials S2). 
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The autophosphorylation of the regulatory subunit CK2β is also reported 
(Fig. 9B). This data suggests a specific event related to CK2α-4E 
autophosphorylation, indeed the P
33 
incorporation in the regulatory 
Coomassie Blue 
PhosphorImager  (Autoradiography) 
NaCl 
(0-50-100 mM) 
CK2α autophosphorylation 
CK2β autophosphorylation  
         (internal control) 
CK2 α-Δ1-336  CK2 α-wt CK2 α-4E 
CK2 catalytic subunit  (no CK2β) 
CK2α-Δ1-336  CK2α-wt CK2α-4E 
CK2 holoenzyme (  CK2α + CK2β) 
Fig. 9A 
Autophosphorylation 
of CK2 catalytic 
subunits (CK2α-wt, 
CK2α-4E and CK2α-
Δ1-336) 
In these two pictures, a 
coomassie stained SDS-
PAGE suggests similar 
amounts of enzymes, while 
the autoradiographic pattern 
shows that CK2α-4E is more 
autophosphorylated than 
CK2α-wt.  
 
 
 
 
 
 
 
 
NaCl 
(0-100-200 mM) 
Fig. 9B: 
Autophosphorylation of CK2 holoenzymes 
In the picture, the autoradiographic pattern discloses that CK2α-4E autophosphorylation is resistant to 
a 200 mM NaCl buffer. The presence of the β subunit does not alter CK2α-4E autophosphorylation 
while completely abolish autophosphorylations in CK2α-wt and CK2α-Δ-1-336. 
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subunit CK2β is comparable between the different holoenzymes (CK2α-
wt, CK2α-4E and CK2α-Δ1-336), while the autophosphorylations of the 
catalytic subunits show a different trend. Our hypothesis is that the four 
amino acidic substitutions in CK2α-4E sustain Ser357 as new 
autophosphorylation site. In particular, the replacement of Thr360 and 
Ser362 with glutamic acids can support the phosphorylation of Ser357 as 
acidic determinants in position n+3 and n+5, respectively.  
This data supports a hierarchical autophosphorylation occurring after the 
intervention of the Cyclin directed kinase 1 (Cdk1), increasing the 
amount of phosphates linked to the C-terminus of CK2α. 
It is also interesting to observe the molecular weight exhibited by the 
CK2α-4E on SDS-PAGE. The four mutations (Serines to Glutamic 
acids) don’t modify significantly the MW of the protein, but in contrast 
CK2α-4E mutant has a slower migration of about 5KDa; the four 
mutations may alter the structure of the C-terminal segment, which may 
interfere with the binding of the SDS. 
This structural alteration of CK2α-4E might suggest a role as bait for 
interactors and substrates related to the C-terminal phosphorylation of 
CK2. Indeed, the altered binding of SDS might reveal an altered affinity 
for different ligands (e.g. CK2 substrates or interactors).     
As useful complement, some experiments were performed to detect an 
alteration in the catalytic activity of the enzyme CK2α-4E, CK2α-wt or 
CK2α-Δ1-336 after autophosphorylation, but the results don't show 
significant modulation of the specific activity (data not shown). Data like 
this supports the idea of a role as bait for interactors and substrates and 
not as regulatory domain. 
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13. Bidimensional electrophoretic analysis of cellular 
extracts phosphorylated by CK2 α-wt and CK2α-4E   
 
A 2D separation of total soluble cellular extracts derived from human 
neuroblastoma cells (SK-N-BE) phosphorylated either by CK2α4E or by 
CK2αwt was performed. After the separation stage, the two patterns of 
radio labeled proteins showed significant differences mainly in "spot 6" 
(Fig. 10). "Gel spot 6" was manually excised for protein identification by 
MALDI-TOF-TOF. Five proteins with putative phosphorylatable sites 
for CK2 have been identified (Fig. 10). 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Fig.10: Experimental scheme 
In the scheme, all the steps of the experiment are proposed. Step1, the phosphorylation in vitro; in step 
2, bidimensional separation; in step 3 analysis of the radio labeled spots; in step 4: identification of the 
proteins by mass spectrometry. 
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These pictures represent three 2D profiles (1 control and 2 samples) (Fig. 
11). In the panel A, the phosphorylation of cellular proteins in presence 
of staurosporine is reported. This compound is a potent but non-specific  
ATP competitive kinase inhibitor [71]; CK2 is able to resist to 
staurosporine (Ki>1µM) instead of many other kinases (Ki=1-100 nM), 
thus all the kinase activity showed in the picture is due to this enzyme.  
The whole cellular extract from neuroblastoma cells is phosphorylated 
by CK2 catalytic subunit α (1,1 µM) and by CK2α 4E mutant, see panels 
B and C respectively. 
Staurosporine in the samples correlates the phosphorylation pattern to 
CK2 alone.     
= Landmark1 (MW:40KDa   pI:5) 
 
= Landmark2 (MW:70KDa   pI:4) 
 
= Landmark3 (MW:100KDa  pI:5) 
 
= Spot 6         (MW>100KDa pI:6) 
 
 
        Control          
(+Staurosporine) 
+CK2α wt 
+CK2α 4E 
 
MW↓ 
MW↓ 
MW↓ 
pH  3 → 10  (IEF-Not linear) 
A 
A 
C 
B 
  Fig. 11:  Bidimensional PAGE autoradiographic profiles 
In the picture, three panels show the phosphorylation profiles of the CK2α wild type and mutant 
4E, and the negative control. The same cellular extract phosphorylated in vitro in the three 
condition reveals few significant difference due to the mutant CK2α 4E able to mime the 
phosphorylation of the Thr344, Thr360, Ser362, Ser370. In particular the spot 6 is significantly 
elevated by the CK2 mutant.    
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The large amount of radio-labeled spots generated by CK2 wt and 
mutant 4E, respectively panels B and C (Fig. 11) confirms the 
extraordinary pleiotropism of this enzyme and its role in a large number 
of biological processes.  
Furthermore, the focusing of all the substrates of CK2 in the acidic 
portion of the IEF Run reveals that main CK2 substrates have an acidic 
isoelectric point (pI), thus in addition to the local consensus also the 
global charge is important.   
The similarity of the phosphorylation patterns of CK2α-wt and CK2α 4E 
confirms the similar values of specific activities of the two forms of 
CK2α measured in the chapter 11. In fact, many spots are identical or 
have negligible alterations in the two panels and only a single spot ("the 
spot 6") has a strong fluctuation (CK2α-wt vs. CK2α 4E), suggesting the 
preferential recognition by CK2α 4E mutant. 
The two dimensional electrophoresis run has been repeated three times 
with independent samples. The "Spot 6" appeared in the presence of CK2 
mutant 4E and it was mild or negligible with CK2α wt.  
In summary, there are many similarities in the phosphorylation patterns 
(B vs. C), but also few local differences ("Spot 6"), suggesting the 
specific recognition of  few proteins due to the "4E" mutations. 
Starting from the mass spectrometry data (supplementary materials S3), 
five proteins have been identified as CK2α-4E putative substrates in the 
"Spot 6" (Tab. 3), but it is probable that some of these proteins are 
merely contaminant (excided in the same band of the CK2 substrate). 
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Tab. 3 
Mass spectrometry identifies five proteins phosphorylated in the sample named "spot 6". For each 
protein, several hypothetical sites have been proposed, which fulfill the minimal CK2 consensus (T/S-X-
X-D/E), but only the phospho-peptides proposed for LSD1 (also denoted by the acronym KDM1A) have 
already been annotated in vivo ( ^=[79]) 
 
Cod. Name Score Molar Weight Match 
Hypothesized sites by  
CK2 acidic consensus 
GANAB 
HUMAN 
Neutral alpha-glucosidase 
AB 
816 107375 46 1-SS244SADPEGHFET 
HGS 
HUMAN 
Hepatocyte growth factor-
regulated tyrosine kinase 
substrate 
511 86848 21 
 
1-QS272EAEEKERLRQ 
 
KDM1A 
HUMAN 
Lysine-specific histone 
demethylase 1A 
314 93484 13 
 
1-S131EDEYYS137EEE(^) 
2-S166EPEEPSGVEG(^) 
 
HS74L 
HUMAN 
Heat shock 70 kDa protein 
4L 
251 95705 8 
 
1-RS74FDDPIVQTERI 
2-S409FEDGS414GECEVF 
3-S832SGEMEVD 
 
OGDHL
HUMAN 
2-oxoglutarate 
dehydrogenase-like, 
mitochondrial 
99 115474 4 
 
1-SS50YMEEMYFA 
2-TVT536LQEFEEEIA 
3-MS789NDDSDAYPA 
4-SS904QDLEEKVA 
 
 
We focused our attention on Lysine Specific histone Demethylase 1 
(LSD1), an enzyme involved in the modification of the histone proteins 
and in chromatin regulation. Indeed these arguments support LSD1 as a 
new CK2 substrate: 
 
1. Dephoure and colleagues described LSD1 phosphorylation in 
cell (without identifying the kinase responsible). Consistent with 
our hypothesis, they identified the phosphorylated residues as 
Ser131, Ser137 and Ser166 [79]. To note that, these residues have   
putative consensus motifs for CK2. 
2. LSD1 is related to mitosis [69], as well as CK2. 
 
LSD1 catalyzes the removal of one or two methyl groups from methyl lysine 
4 and 9 of histone H3 [49, 72]. 
Shuang and colleagues reported that LSD1 is required during the mitotic 
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phase and its breakdown leads to chromosomic instability [69], a similar 
phenotype has been observed in HeLa cells expressing the mutant CK2α-4E 
[35]. The more recent finding that unbalanced levels of Histone H3 di-
methylated lysine 4 has been correlated to defective incorporation of the 
centromeric protein CENP-A in kinetochore and then to an aberrant 
chromosomes segregation due to a defective mitotic spindle [70], fits with 
our hypothesis and further confirms the relation CK2/LSD1.  
In summary, LSD1 clearly appears a possible link between CK2 and the 
chromosome instability; many independent observations support a network 
involving CK2α phosphorylation by Cdk1 and LSD1 phosphorylation by 
CK2. The misregulation of this pathway might lead to chromosome 
instability by a defective formation of the mitotic spindle.  
 
14. CK2α-4E phosphorylates the recombinant LSD1, 
but also CK2α-wt is able to recognize LSD1 in vitro 
 
The LSD1 phosphorylation is confirmed in vitro (Fig.12B). The minimum 
observable quantity of phosphorylated LSD1 by autoradiography is 50 ng 
(26 nM), suggesting LSD1 as a very good CK2 substrate. 
Surprisingly, also CK2α-wt is able to phosphorylate the recombinant LSD1; 
indeed the phosphorylation appears similar to CK2α-4E (Fig. 12A and 12B).  
In the graph.1 are reported the DLU values measured in the kinetic 
experiments, which refer the amount of radio labeled phosphates 
incorporated in the full length band of LSD1. 
In the table 4, the values of the kinetic constant (Km and Vmax) of CK2α-wt 
and CK2α-4E are reported.   
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The values of Km and Vmax for the LSD1 phosphorylations are very similar 
0 
500 
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1500 
2000 
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0 100 200 300 400 500 600 
V
 (
D
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 x
1
0
0
0
) 
nM (LSD1 concentration)  
Graph.1 : LSD1 phosphorylation kinetics  
LSD1 
phosphorylation 
(CK2awt) 
LSD1 
phosphorylation 
(CK2a4E) 
Enzyme Km Value Vmax 
Confidence  
(R2) 
CK2α-wt 393.0 nM  7,9 x10
6 DLU/mg x min 0.981 
CK2α-4E 367.9 nM  7,9 x10
6 DLU/mg x min  0.968 
Fig. 12A and 12B: 
Phosphorylation of recombinant LSD1 by CK2α-wt and CK2α-4E 
LSD1 is phosphorylated performing a kinetic analysis; eight concentration points are tested (0-531 nM). 
  
 
 
 
 
Tab 4: 
DLU Values Plotting, Km and Vmax of the reactions 
The signals of the autoradiographic profiles are converted by OptiQuant software (Perkin Elmer) 
in values of Density Light Units (DLU). DLU values of the two kinetics are plotted by Prism 5 
(Graphpad Software); Km and Vmax are estimated by nonlinear regression.  
 
    0   26   53   106    159  212   266   531      nM     [LSD1] 
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and a significant difference between the two enzymes is not present. The 
nanomolar range of the Km value suggests that LSD1 phosphorylation in 
vivo could be very effective, as well as in vitro. Consistent with this, LSD1 
phosphorylation has been already reported in cell by several independent 
authors [69, 79].   
As useful complement, the autoradiography of the LSD1 phosphorylation 
reveals three mayor bands in the lane (data not shown). The upper one is the 
full-length protein of 94 KDa (observable in the Fig. 12A and 12B), while 
the other two bands (40 KDa and 25 KDa) are phosphorylated fragments of 
LSD1. 
Repetitions of the experiment suggested a spontaneous degradation related to 
the freeze and thaw of LSD1 solution. These fragments appear 
spontaneously after the FPLC purification and increased with time 
(supplementary materials S4). WBs disclose the presence of the N-terminal 
region in all the fragments and the absence of the C-terminus (data not 
shown), confirming the phosphorylation at the N-terminal portion of LSD1.  
Moreover, full-length band is split in two bands with very similar MWs 
(Fig.12A and 12B). The complete separation of the two bands requires an 
SDS-PAGE with low acrylamide concentration (<8%), thus sometimes the 
two bands can appear as a single signal using gel with higher acrylamide 
concentration (e.g. Fig. 13).   
 
 
15. Characterization of LSD1 phosphorylation in vitro 
and the effect of CK2β 
  
The mechanism which favors the LSD1 phosphorylation by CK2α-4E in 
cellular extract has not been disclosed yet, indeed the Km values measured 
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are very similar, suggesting that an indirect mechanism enhances LSD1 
phosphorylation in cellular extract. 
Additional experiments of phosphorylation by CK2α-wt, CK2α phospho-
mimetic mutant 4E and CK2α C-terminal truncated Δ1-336 in the absence 
and in presence of the regulatory subunit CK2β were performed.    
Again no differences have been detected using as enzyme: either CK2α-4E, 
or CK2α-wt, or CK2α-Δ1-336 (Fig. 13A and Tab. 5A). Indeed, all the forms 
of CK2α in the presence of CK2β equally phosphorylate LSD1 (Fig. 13B 
and Tab. 5B), while the α-casein phosphorylation used for the comparison of 
the three CK2 forms confirms the similar specific activities of the 3 
enzymes. 
In summary, the stimulation of CK2β increases the amount of phosphates 
incorporated, but the C-terminal segments of CK2α (wt, 4E in comparison to 
Δ1-336) don't alter LSD1 phosphorylation. 
It seems predictable that the difference observed in 2D separations depends 
by interactors able to recruit CK2α-4E and/or to block CK2α-wt. 
These interactors are absent in the in vitro assay and their lacking allow a 
generalized phosphorylation of LSD1. 
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 CK2 α-wt CK2 α-4E CK2 α-Δ1-336 
Substrate: LSD1 0.58 x106 DLU 0.68 x106 DLU 0.77 x106 DLU 
Substrate: LSD1 (CK2β effect) 1.28 x106 DLU 1.38 x106 DLU 1.48 x106 DLU 
Effect of  CK2β +124 %  +101 %  +91 %  
 
 
 
 
 
 
 
 
   
 
 
CK2 α-wt  CK2 α-4E CK2 α-Δ1-336 
Substrate: α-Casein 2.7x106 DLU 2.5 x106 DLU 3.0 x106 DLU 
Ratio 90% 83% 100 
    
LSD1 phosphorylation by the CK2 α-wt CK2 α-4E CK2 α-Δ1-336  
 
 
  
CK2 α-wt 
CK2 α-4E 
CK2 α-Δ1-336  
CK2 α2β2 (α-wt) 
CK2 α2β2 (α-4E) 
CK2 α2β2 (α-Δ1-336) 
+ CK2 β 
(Holoenzyme) 
no 
CK2 β 
CK2 β 
 
 LSD1 
 
 
 
 
  
CK2 α-wt 
CK2 α-4E 
CK2 α-Δ1-336  
Fig. 13A: 
LSD1 phosphorylation by the CK2α 
subunits and CK2 holoenzymes 
(autoradiography) 
LSD1 is phosphorylated by the catalytic 
subunits CK2α-4E, CK2α-wt and CK2α-Δ1-
336, and by holoenzymes (α2β2). CK2β 
stimulates the phosphorylation, while no 
difference are reported about the action of C-
terminal segments of CK2α (wt and mutants). 
    
 
 
 
 
Tab. 5A:  
 
DLU values are 
extrapolated by the 
fig.5a. The three  
forms of CK2α 
phosphorylates 
LSD1in a  similar 
manner.  
Specific activity control   
(substrate: α-casein) 
 
Fig. 13B and Tab. 5B 
Specific activity controls of CK2α-4E, CK2α-wt and CK2α-Δ1-336 
The three forms of CK2 tested are analyzed against α-casein to ensure a similar value of specific 
activity. 
-Results and discussion- 
  
       48 
 
  
 
16. LSD1 phosphorylation occurs at physiological 
ionic strength 
 
LSD1 phosphorylation by CK2 (α2β2) in performed in different 
conditions of ionic strength. Data suggests that the phosphorylation 
could be very effective in a physiologically buffer; the best condition 
tested is 130 mM NaCl (Fig. 14 and Graph. 2). 
The inhibitory effect by high saline buffer (>130 mM NaCl) reflects the 
susceptibility of CK2 to ionic strength and doesn't seem related to any 
particular interference in relation to the interaction CK2/LSD1. 
Consistent with this α and β caseins phosphorylations are affected in a 
similar way (data not shown). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 LSD1  
      NaCl    
                  40 -  80 - 130 -180 -  230  mM 
 
  
 
 
LSD1 is phosphorylated by the CK2 holoenzyme; a 
gradient of saline concentrations is tested. The 
phosphorylation is dependent to ionic strength, as 
well as almost all the CK2 substrates, and the best 
condition tested is 130 mM NaCl.  
 
 
 
 
 
 
 
 
 
 
 
In the graphic are reported the values of DLU 
measured by the figure 14, the estimations represent 
the amount of phosphates incorporated into LSD1 
after 10 minutes of reaction.  
mM 
Fig. 14 and Graph.2 
Effect of ionic strength on LSD1 phosphorylation by CK2 holoenzyme 
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17. Polycations and histone proteins modulate CK2 
and repress LSD1 phosphorylation 
 
In figure 15, the phosphorylations of β-casein and LSD1 by CK2 are 
increased in presence of CK2β. In figure 16 and in the table 6, β-casein 
phosphorylation by the CK2 holoenzyme is positively modulated by 
poly-L-lysine, while LSD1 is inhibited by the same compound. 
These data suggest that LSD1 is a class I substrate, recognized by both 
the holoenzyme and the catalytic subunit α [7]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15: 
Effect of CK2β subunit on LSD1 phosphorylation by CK2 holoenzymes 
(autoradiography) 
 
LSD1 and β-casein phosphorylations by CK2 are analyzed. LSD1 phosphorylation is stimulated by the 
presence of CK2β, as well as, β-casein.  
 
LSD1 (400 ng /4.1pmol) 
           β-Casein (5 ug / 166 pmol) 
CK2β 
     ( ratio α:β = 1:0 - 1:1 - 1:4) 
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Natural counterparts of poly-L-Lysine are polyamines and monoamines 
(e.g. spermines, spermidines and serotonin), but also positively charged 
proteins (e.g. histone proteins).  
The role of these proteins such as LSD1 phosphorylation regulators 
appears predictable, indeed LSD1 is commonly bound to histone proteins 
in vivo. Histones are the substrates of LSD1, but in our case are also 
regulatory elements.     
 Poly-l-Lysine 0 µM Poly-l-Lysine 1 µM Poly-l-Lysine 3 µM 
LSD1  
phosphorylation 
100% 55% 33% 
β-casein  
phosphorylation 
100% 131% 180% 
Poly-L-lysine 
(0 - 1 - 3 µM) 
       LSD1 (400 ng / 4.1 pmol) 
      β-Casein (5 ug / 166 pmol) 
 
 
Fig. 16 and Tab.6: 
The effect of poly-L-lysine on the LSD1 phosphorylation 
LSD1 is phosphorylated by the CK2 holoenzyme; the effect of a gradient of poly-L-lysine (0-3μM) is 
tested. The phosphorylation of β-casein is increased, while LSD1 phosphorylation is dramatically 
affected by polycations.  
In the table are reported the values of DLU measured by the Fig.16, the estimations represent the 
amount of phosphates incorporated into LSD1 after 10 minutes of reaction. The phosphorylation of 
LSD1 is affected by poly-L-lysine. 
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In our experiments (Fig. 17 and Tab. 7), LSD1 phosphorylation was 
strongly reduced in presence of 0.6 - 1.2 µg/µl of histone sub-fraction 
lysine rich f1 (a mixture of histone proteins enriched of the H1 subunit). 
H1 is particularly abundant in condensed chromatin and in low 
transcribed region, where the histone proteins acquire their higher 
positive charge.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In vitro many clues of a strong modulation of CK2 by polyamines and 
histone proteins have been already proposed [80], but currently no data 
 
Histone 
subfraction  
0.0 µg/µl 
Histone 
subfraction  
0.6 µg/µl  
Histone 
subfraction  
1.2 µg/µl 
LSD1 
phosphorylation 
100% 46% 34% 
β-casein 
phosphorylation 
100% 151% 150% 
   LSD1 (400 ng / 4.1 pmol) 
 β-Casein  (5 μg / 166 pmol) 
Histone sub-fraction lysine rich f1  
(0 - 0.6 - 1.2 µg/µl) 
Fig. 17 and Tab. 7 
The effect of histone proteins on the LSD1 phosphorylation 
Histone proteins are common interactors of LSD1, in the picture LSD1 is phosphorylated by the CK2 
holoenzyme in three condition (histone proteins 0 - 0.6 - 1.2 µg/µl). The phosphorylation of β-casein 
is stimulated by these proteins, while LSD1 phosphorylation is dramatically affected by polycations.  
In the table 7 are reported the values of DLU measured by the fig.17, the estimations represent the 
amount of phosphates incorporated into LSD1 after 10 minutes of reaction. 
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have been published to demonstrate the physiologic occurrence of this 
modulation.  
LSD1 is commonly bound to histone proteins and may be an excellent 
example of CK2 substrate regulated by polycations in vivo. 
Hereby we hypothesize that the histone proteins charge modulates CK2 
action and then the LSD1 phosphorylation. Indeed, histone proteins are 
very close to CK2 during the LSD1 phosphorylation and a direct 
interaction seems predictable.  
The additional findings that the positive charges of histone proteins can 
be altered by several post-translational modifications (e.g. histone 
acetylations) suggest that these events might indirectly modulate LSD1 
phosphorylation by CK2.  
In summary, CK2 is able to phosphorylate LSD1 when it is located to a 
specific portion of DNA. These loci are characterized by a low positive 
charge and the hyperacetylation of the histone proteins; for these reasons 
CK2 might generate an essential complement for the gene regulation and 
might explain many controversial observations about LSD1 (e.g.  the 
demethylation of the Lys9 instead the Lys4).  
In our model shown in figure 18A, CK2 preferentially phosphorylates 
LSD1 near active genes, leading to a subsequent modulation of the 
methylation.  On the other hand, CK2 fails to phosphorylate LSD1 when 
it binds heterochromatin (high positively charged histones and poor in 
term of acetylations).  
To note that, LSD1 phosphorylation may alter the epigenetic marks, but 
at the same time epigenetic marks alter the CK2 activity, thus a feedback 
mechanism is generated (Fig.18B).     
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The action in vivo of poly-L-lysine, spermines and histone proteins on CK2 
is still matter of debate. LSD1 is a very particular example of CK2 substrate, 
Alteration of LSD1  
activity by CK2  
Modulation of CK2 by 
histone modifications  
Fig. 18B 
CK2 modulation by histone proteins and LSD1 modulation by CK2 might form a 
circular feedback mechanism. 
  
The positive charges of histone proteins are greatly dependent to the modifications on the protruding tails, 
in particular by acetylations. Hereby, we hypothesized a feed-back mechanism able to modulate LSD1 
phosphorylation by the modulation of CK2. Indeed CK2 is strongly affected by histone proteins during the 
phosphorylation of LSD1  
Fig. 18A  
CK2 recognizes preferentially LSD1 in hyperacetylated loci  
Actively transcribed genes are marked by hyperacetylated histones, which are characterized by a low 
positive charge; in this loci CK2 is not repressed and LSD1 phosphorylation is allowed. 
1° 
2° 
Hyperacetylated 
nucleosomes 
CK2 intervention 
CK2 intervention 
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and might be physiologically regulate by histone proteins, indeed histones 
can directly interact with CK2 during the recruitment of LSD1. 
 
18. Phosphorylation of LSD1 in vivo 
 
LSD1 is hyper-phosphorylated in nocodazole-synchronized cells, and it is 
required for a proper chromosomal segregation during mitosis [69].  
We have confirmed the conclusion about the hyper-phosphorylation of 
LSD1, but furthermore we suggest that LSD1 phosphorylation is widespread 
in the whole cell cycle in our cellular model (SK-N-BE). 
Calf Intestinal Phosphatase (CIP) de-phosphorylates LSD1 in a cellular 
extract as shown in Fig. 19A. LSD1 incubated with CIP has an altered 
mobility in SDS-PAGE. The shifting is very little but detectable and 
reproducible.   
The molecular weight of LSD1 in SK-N-BE cells is due to presence of 
phosphorylated residues and it can be reduced by de-phosphorylation. 
In our experiment, it is very interesting the observation of the 
phosphorylation in the whole cell cycle in SK-N-BE cells. Indeed, Shaung 
and colleagues [69] got great emphasis to the LSD1 phosphorylation 
occurring in the M phase in HeLa cells, correlating it to the increased 
amount of LSD1 during mitotic events. 
In contrast our data with SK-N-BE cells do not show any altered migration 
of LSD1 attributable  to the pro-mitotic phosphorylation (Fig. 19B). 
Although, additional experimentation is required, it seems that LSD1 is 
constitutively phosphorylated in SK-N-BE cells. 
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             SKNBE cells                 HeLa cells 
 
 
 
This finding suggests that LSD1 phosphorylation plays a role during the 
whole cell cycle, supporting cell survival in SK-N-BE tumor cells.  
In a non tumor cell (e.g. Fibroblasts) and in tumor cell without the 
constitutive phosphorylation of LSD1 (e.g. HeLa cells), LSD1 has two levels 
of regulation: the first one is related to the mitotic phase, it needs the 
complete saturation of the phospho-acceptor sites and it is associated to a 
Ctrl 30°C 1h 
+ Phosphatase CIP 30°C 1h  
WB (AB vs.LSD1 C-Terminus)  
Fig. 19 
LSD1 is commonly phosphorylated in human neuroblastoma SKNBE cell 
In the picture A, SKNBE cell proteins extracts (20µg) were incubated in ice, at 30°C, and in presence of 
phosphatase CIP at 30°C for 1h. After the incubation of the samples have been subjected to SDSPAGE 
and blotted onto PVDF membranes. Molecular weight of LSD1 has been revealed by a C-terminal 
antibody. Consistent with the experiments of Shuang and colleagues [62], the molecular weight of LSD1 
is reduced by the action of phosphatase. 
In the picture B, the nocodazole treatment of SKNBE cells does not induce an altered migration of LSD1 
in contrast to the reported experiment.  
 
 
 
Ctrl 0°C 1h 
WB (AB vs.LSD1 C-Terminus)  
       Asn   Syn0 Syn2  Syn4  Asn 
               
                G2-M→G1                                                                                            G2-M→G1 
LSD1 is required for chromosome segregation during mitosis [69] 
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stronger modulation of LSD1 [69], while the second one is associated to a 
smooth modulation of LSD1 and it is related to the whole cell cycle. 
 
19. LSD1 phosphosites identification by mass 
spectrometry 
 
In the sequence of LSD1 (O60341 KDM1A_HUMAN) there are at least 4 
putative sites fulfilling the consensus of CK2 (Fig. 20A). Three of these 
residues (Ser131, Ser137 and Ser166) have been already reported to be 
phosphorylated in cells [79], but no data about the kinase responsible are 
available.  
In order to identify the residues which are phosphorylated in vitro by 
CK2α4E, LSD1 was incubated with ATP in vitro.  The exhaustive 
phosphorylation has been performed by the incubation of 50 pmol of LSD1 
[0,5 μM] in presence of 10 pmol of  CK2α4E [0,1 μM] and 10 nmol of ATP 
[100μM] for 40 minutes at 30°C.  
Phosphorylated LSD1 was excised from SDS-PAGE, subjected to tryptic 
digestion, purified by TiO2 affinity chromatography and analysed by MS 
(LTQ Orbitrap XL Termofisher scientific). 
Two sites are detected: Ser131 and Ser166 (Fig. 20B and 20C). 
Manual refinement analysis discloses also Ser137 as phospho-residues in a 
di-phosphorylated peptide, containing both Ser131 and Ser137 (Fig. 20C). 
The re-fragmentation analysis doesn't describe Ser137 such as a single 
phospho-residue, it might suggest the opening of this sub-domain after the 
first phosphorylation (Ser131), leading the exposure of the Ser137 to CK2 in 
a hierarchical process. 
Although we cannot exclude that other kinases phosphorylate LSD1, our 
data provide the clear-cut demonstration that LSD1 is a new substrate of 
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CK2 in vitro and in vivo.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.20 
Mass spectrometry reveals several phosphorylated peptides 
  
In the picture A, the four putative 
CK2 directed sites are reported, 
while in the picture B the three 
sites detected by mass 
spectrometry are reported. 
In the picture C, manual 
spectrometry reveals a di-
phosphorylated peptide Ser131 
and Ser137 and a mono 
phosphorylated peptide Ser166. 
 
A 
 
 
 
 
 
B 
              LSD1 phospho-sites identified by mass spectrometry 
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20. Mutagenesis of the vector pTP6_Ko-
FLAG/LSD1wt  
 
Mass spectrometry demonstrates the phosphorylation of Ser131, Ser137 and 
Ser166 by CK2. Molecular modeling of this region suggests a metastable 
structured domain with Ser131, Ser137 and Ser166 exposed to the solvent. 
The additional analysis of Protein-Protein Docking complex between LSD1 
and CK2α, obtained using Zdock software, followed by 100 ns of Molecular 
Dynamic (NAMD) further suggests the ability of these peptides (and in 
particular the Ser131) to enter in the catalytic site of CK2 (data not shown). 
To shed light on the role of the LSD1 phosphorylation, we planned to  
mutagenize the two Ser residues (Ser131 and Ser137), while the Ser166 
mutagenesis was immediately excluded for reasons of time.   
Starting from the mammalian vector pTP6_Ko-FLAG/LSD1wt (Fig.21), I 
tried many times to perform the mutations, using the Quick-Change 
Mutagenesis Kit, but no colonies were obtained by this strategy.  
To bypass the problem, an alternative method has been developed (Fig. 22) 
and two Ser131 mutants have been obtained ( S131E and S131A).  
Ser131 is the most abundant phosphoresidues detected by mass spectrometry 
and the crucial site in the Molecular Docking Analysis. Thus, it might have a 
role in LSD1 regulation alone. 
Hence, S131A and S131E mutants are essential tools to understand the 
effects of the LSD1 phosphorylation, a phospho-defective and a phospho-
mimic mutant respectively. The study of transfected cells with the mutant 
forms of LSD1 can provide evidences about the function of Ser131 
phosphorylation in cell and in general suggest a role for the phosphorylation 
of LSD1 by CK2. 
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21. Transfections of  LSD1 wt and LSD1 mutants in 
HEK293T cells  
 
Fig. 21 
pTP6-Kozac-Flag-human 
LSD1  
  
In the picture is reported the 
vector pTP6-Kozac-Flag-human 
LSD1 used for transfecting 
HEK293T cells. 
 
The mutated fragment BspE1-AGEI has been excided by pGEMt-easy-LSD1wt and ligated into a 
pTP6_Ko-FLAG/LSD1 vector linearized by the same enzymes.  
The insertion has been verified by EcoR1 digestion, obtaining data about the full length gene. Finally, 
the genes have been sequenced to exclude unexpected mutations. 
 
 
Fig. 22 
Scheme of the 
mutagenesis  
 
 
A mutated PCR product of 820 
nt has been obtained by PCR 
with the primers Ser131Glu1°for 
(or Ser131Ala1°for) and 
LSD1exon8rev. A 73nt fragment 
HindIII- (Ser131mutated)-
HindIII has been excided from 
the PCR product and ligated 
into a cloning vector pGEMt-
easy-LSD1wt  linearized by the 
same restriction enzyme. The 
orientation of the insertion has 
been verified by sequencing.  
mutated  
pTP6 vector 
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The major aim of this piece of work is to demonstrate that cells transfected 
with LSD1 mutants have a different phenotype respect to the wt one. The 
first step to achieve this target is to generate stable and transient transfection 
of HEK293T cells (Fig. 23).   
Transfections with the pTP6-Ko-LSD1 wt and mutants were performed and 
stably transfected cell lines expressing LSD1 and Puromycin N-acetyl-
transferase have been achieved (Fig. 24). 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 23 
Scheme of stable and 
transient transfection 
protocol 
 
 
A linearized plasmid was transfected 
by lipofectamines for 24h. Transient 
expression of was reported for 7-10 
days by anti flag AB and anti Pan 
LSD1. 
From the day 10,  3 selection 
treatments with puromycin (1- 3 -10 
ug/ml) were performed. Cells 
adhesion after the puromycin 
treatments disclosed the selection 
and non transfected cells were lost 
together the exhausted media 
All the survived cells were positive to 
the construct and expressed LSD1 at 
high level. 
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Transfected cells expressing LSD1 wt and mutants are viable. Now, a 
catastrophic phenotype mediated by the misregulation of LSD1 Ser131 
phosphorylation can be excluded and it seems predictable that the phenotype 
HEK293T Cells - Stable 
transfected- Day 20 
 pTP6_Ko-FLAG/LSD1 
Ser131Ala 
HEK293T Cells - Stable 
transfected- Day 20 
 pTP6_Ko-FLAG/LSD1 
Ser131Glu 
HEK293T Cells - Stable 
transfected- Day 20 
 pTP6_Ko-FLAG/LSD1  
wild type Ser131 
 
Fig. 24 
pTP6_Ko-FLAG/LSD1 transfected HEK293T clones. 
 
Three clones of cells HEK293T, transfected by lypofection, expressing LSD1 wt (A), LSD1 Ser131Ala (B) 
and LSD1 Ser131Glu (C) are shown. All the three clones were viable.  Each picture was collected by a 10X 
objective.    
 
A 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
C  
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may be the abnormal modulation of several mRNAs, or the alteration of the 
LSD1 complex.      
 
22.  Analysis of LSD1 expression in transfected cells 
 
LSD1-FLAG protein expressions have been analyzed at different times by 
WB (day 2, 10, 20 and 40). Each line (Wt, Ser131Glu, and Ser131Ala) 
showed a stable expression of the exogenous proteins, although a gradual 
loss of expression was evident 40 days after the transfection.   
Anyway, LSD1 was strongly expressed for many days, probably 10-100 fold 
higher than the endogenous form. As expected, the exogenous LSD1 forms 
(detected by a Flag specific antibody) were present only in transfected lines, 
while the pan LSD1 WB indicates dramatic increase in LSD1 cellular 
concentration, detecting the endogenous LSD1 and the transfected one (Fig. 
25A and 25B). 
All the forms of LSD1 (wt, Ser131Ala, Ser131Glu) codified for a stable 
protein and no evidence of toxicity was detected.  
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23. Nuclear localization of the LSD1 mutants 
B-Actin 
Pan LSD1  
(AB vs. C-terminus) 
Ctrl LSD1 
wt 
LSD1 
S131A 
LSD1 
S131E 
 
Fig. 25 
Analysis of the expression of transfected LSD1 in HEK293T cells. 
 A: Two WBs are reported. The lower one reports the amount of B-actin, and is used as standard, while the 
other WB reports the amount of the transfected LSD1 by a C-terminal epitope (present also in the 
endogenous LSD1). Each sample was subjected in two lanes; 5 and 10 µg were used. 
B: The transfected LSD1 is detected by an antibody raised against the Flag N-terminal peptide.   
  
 
Endogenous LSD1              Burned signals 
Ctrl LSD1 
wt 
LSD1 
S131A 
LSD1 
S131E 
B-Actin 
 
LSD1 
(AB Vs. Flag peptide) 
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The subcellular fractionation (Nucleus vs. Cytoplasm) suggests the ability of 
the mutated proteins as well as the transfected LSD1 wt to have access in the 
nucleus (Fig. 26). Thus, both mutants of Ser131 don't affect the nuclear 
import and the protein solubility. 
Consistent with this, a large amount of flagged LSD1 are usually recovered 
by cellular lysis (in comparison to the amount of LSD1 recovered by control 
cells), suggesting the good solubility of the protein and the absence of 
inclusion bodies.  
 
 
 
 
 
 
 
 
 
 
 
β-Lamin (Nuclear marker) 
LSD1 (AB vs. Flag)  
Nuclear fraction 
Cytoplasm 
 
 
Fig. 26 
LSD1 mutants Ser131Ala and Ser131Glu are localized in the nucleus. 
  
In these pictures, WBs report the mobility of LSD1 and the intake in the nucleus. The lower one reports that 
the majority of LSD1is in the nucleus as well as β-Lamin, a nuclear protein.  
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24. LSD1 overexpression alters mRNAs level of 
several genes, while the mutation Ser131Ala impairs  
the modulation of FoxA2 
 
LSD1 activity has a great impact on gene transcription, indeed LSD1 
silencing down-regulates the transcription of many genes [82]. In particular, 
FoxA2, EOMES, BMP2, HNF4, Sox17, Pax6 and many other mRNAs are 
important targets of the LSD1 action. 
To understand if phosphorylation of LSD1 by CK2 can play a role in altering 
the expression of different genes, stable transfected lines (LSD1-wt, LSD1-
Ser131Ala, and LSD1-Ser131Glu) and control line (non-transfected) have 
been analyzed by Real time PCR.  
The primers were designed to detect three mRNAs modulated by LSD1 
(Pax6, FoxA2 and BMP2), two LSD1 interacting proteins (Rcor2 and 
ZNF198), GAPDH and CK2β as control (Tab. 9). 
mRNAs of each stable transfected clones and of control line were extracted, 
reverse-transcribed and amplified with specific probes.  
Each signal is standardized by the values of GAPDH (housekeeping gene) 
allowing a relative quantification of each mRNA. Similarly, the relative 
quantifications are divided to the amount in control cell allowing a direct 
comparison of the effects of the transfection in each condition. 
Real-time PCR discloses a big interference due to the transfection on the 
mRNA transcription (Tab. 10 and Graph. 3); several mRNAs are positively 
stimulated. For example, all the forms of LSD1 increase significantly 
ZNF198 (Zinc finger MYM-type protein 2) in comparison the control. This 
observation suggests that all the three enzymes are biologically active; 
indeed the alterations are similar in each transfected line. 
BMP2 (Bone morphogenetic protein 2) is increased by the transfection of 
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LSD1wt in comparison to the control, but moreover LSD1 Ser131Ala seems 
particularly able to increase this mRNA. Consistent with this BMP2 is 
commonly modulated by LSD1 activity [82]. 
To note that, LSD1 Ser131Ala mutation significantly increases also Corest2 
and FoxA2 mRNA level in comparison to the mutant Ser131Glu and the 
wild type LSD1. 
In particular, FoxA2 (Forkhead box protein A2) appears as a good example 
of this effect; in the table 10 its transcription is significantly reduced in cell 
expressing LSD1 wt and LSD1 Ser131Glu, but not in cells expressing LSD1 
Ser131Ala, suggesting that the mutation impairs the modulation of FoxA2 
mRNA. 
  
 
 
 
mRNA Note 
CK2β CK2 subunit and internal control 
GAPDH Housekeeping gene  
BMP2 transcriptional factor 
FoxA2 transcriptional factor 
ZNF198 transcriptional factor and LSD1 interactor 
Corest2 LSD1 interactor 
Pax6 transcriptional factor 
 
 
 
 
 
 
 
 
 
Tab. 9 
 
mRNAs detected by Real-time PCR. 
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LSD1 Ser131Ala significantly enhances the transcription of several mRNAs 
in comparison to the other two transfected lines. 
Currently, it is not clear if these increments lead to an abnormal modulation 
for the cell, indeed the fold-changes are not so important, but it suggests that 
the LSD1 Ser131 phosphorylation is involved in the modulation of several 
mRNAs, opening a new insight in the action of LSD1.    
mRNA Ctrl 
LSD1 WT 
 (fold change) 
LSD1 Ser131Ala  
(fold change) 
LSD1 Ser131Glu  
(fold change) 
CK2β 1 0,88 -12% 1,05 +5% 0,98 -2% 
Corest2 1 0,8 -20% 1,21 +21%* 0,72 -28%* 
Pax6 1 0,63 -37% 0,84 -16% 0,87 -13% 
FoxA2 1 0,52 -48%* 1,28 +28% 0,56 -44%* 
ZNF198 1 1,48 +48%* 2 +100%* 1,51 +51%* 
Bmp2 1 1,77 +77%* 2,51 +151%* 1,96 +96%* 
 
Graph. 3 
Relative quantification of the mRNAs  in HEK293T cells transfected by LSD1 wt 
LSD1 Ser131Ala and LSD1 Ser131Glu in comparison to control cells ( 100%). 
 
 
Tab. 10 
 
Relative quantification of the mRNAs in HEK293T cells transfected by LSD1 
wt LSD1 Ser131Ala and LSD1 Ser131Glu in comparison to control cells (=1). 
 
Values are means of 6 experiments. GAPDH values were fixed at 1 (100%) in each cell of this table 
to get comparable results, furthermore also mRNAs of non transfected HEK293T cells were fixed at 1 
to get comparable data in each column (*= at least p<0.05 ) .  
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25.     FoxA2 protein expression is reduced by LSD1 
Ser131Glu mutant in comparison to LSD1 Ser131Ala   
 
Quantitative Real-time PCR revealed that FoxA2 mRNA level is 
significantly reduced in cells overexpressing LSD1 and LSD1 Ser131Glu, 
but not affected by the mutant LSD1 Ser131Ala.  
According to the quantification of the mRNAs, FoxA2 protein is reduced in 
cells overexpressing LSD1wt and LSD1 Ser131Glu in comparison to non 
transfected cells and cells expressing the mutant Ser131Ala (Fig. 27).  
As reference many proteins are also checked. CK2α and α' seems unaffected 
by LSD1 over-expression, as well as β-actin and β-lamin.    
 
 
 
 
 
 
β-Actin 
CK2α subunit 
Flagged LSD1 
CK2α' subunit 
 
β-Lamin 
 Memory of  the LSD1  
40KDa fragments 
Main signal (50kDa) 
Main signal (40 kDa) 
Main signal (120 kDa) 
Main signal (42 kDa) 
Main signal (48 kDa) 
FoxA2 (≈70KDa) 
 
Fig. 27 
Analysis of protein expression in transfected cells. 
WBs report the amount of several proteins in transfected cells. FoxA2 protein is reduced in cells 
overexpressing LSD1wt and LSD1 Ser131Glu in comparison to non transfected cells and cells expressing 
the mutant Ser131Ala. However, the other proteins are generally unaffected by LSD1 overexpression.    
Main signal (70 kDa) 
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25A     ZNF198 protein is elevated in LSD1 transfected 
cell lines 
 
The result about ZNF198 mRNA has been verified by WB. To understand 
this event many other players of the CoREST complex have been analyzed. 
In figure 28, ZNF198, LSD1 Corest1 and HDAC2 are elevated in term of 
protein level in comparison to the lanes of control cells (non transfected). 
All the players of the CoREST complex are increased. Now it seems 
predictable that this is an indirect effect of the increasing of LSD1. Indeed, 
the complex formation is an essential step to have a functional LSD1.  
We conclude that the increase of a single protein of this complex leads to the 
incrementation of several interacting proteins (Fig. 29). 
As useful complement, ZNF198 protein is equally elevated by both of the 
LSD1 mutants. The increase in mRNA concentration, showed by the mutant 
Ser131Ala in comparison to the Ser131Glu mutant, was due to the error bar. 
(see graph.3 - pag.67). 
    
 
 
 
 
 
 
 
 
  
 
Fig. 28 
Analysis of the expression of 
several LSD1 interacting 
proteins in transfected cells. 
  
 WBs report the amount of several 
proteins in transfected cells. ZNF198 
is increased in term of mRNA, but 
also in term of protein. Many 
interactors of LSD1 are increased, 
suggesting the general increase of the 
proteins of the LSD1 complexes.   
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Fig. 29 
General increase of LSD1 complex proteins as a consequence of LSD1 increment  
  
In the picture are summarized the results of the WBs of the Fig.28, suggesting the general 
elevation of the proteins of this complex.    
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26.  LSD1 complex immunoprecipitation 
  
The kinetics of phosphorylation of LSD1 by CK2 (α-wt and α-4E 
mutant) didn’t suggest any advantage for the mutant CK2α-4E in 
comparison to CK2α-wt, while the 2D experiments specifically associate 
LSD1 phosphorylation only to CK2 phospho mimetic mutant 4E. 
To explain the preferential phosphorylation of LSD1 by the mutant 
CK2α4E a hypothesis of a direct interaction between LSD1 and CK2 has 
been formulated, involving the C-terminal domain of CK2α. Consistent 
with this, experiments of confocal microscopy disclose that 
phosphorylated CK2 overlaps the DAPI staining signal, localizing this 
form of CK2α near the chromatin, and thus suggesting a direct 
interaction of CK2 with DNA and DNA/proteins complexes during the 
mitosis [36].      
To test a direct interaction between LSD1 and CK2 in vivo, we 
performed immunoprecipitation of LSD1 and data about the IPs 
complexes have been collected.  
In IPs of lysates of HEK293T cells transfected with pTP6_Ko-
FLAG/LSD1 vectors (Wt, Ser131Ala, Ser131Glu) (Fig. 30), a large 
amount of flagged LSD1 is immunoprecipitated; the interactive protein 
Corest1 is co-immunoprecipitated in equimolar ratio and HDAC2 is also 
present. 
Furthermore, a small amount of CK2α is also co-immunoprecipitated. 
The interaction is almost undetectable in comparison with Corest1 and 
HDAC2 but the signal is clearly significant considering the negative 
control (lane IP- of Fig. 30).  
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The CK2 signal becomes detectable if a large amount of LSD1 is 
immunoprecipitated and anyway the CK2α signal in the IP lane appears 
lower than its response in the surnatant (10 μg of cellular lysate), 
suggesting that only a minor fraction of CK2 is bound to LSD1 in a non-
equimolar ratio.  
We can conclude that CK2 is not a stable component of this complex, 
and the action of CK2 may be related to its kinase activity.  
To note that, the mutated LSD1 proteins (Ser131Ala and Ser131Glu) do 
not significantly modify the interactions of Corest1 and HDAC2, 
suggesting that the binding of several important players of this complex 
are not regulated by Ser131 phosphorylation.  
Input Ctrl 
Sur. 
IP 
Sur. 
IP 
Sur. 
IP (-) 
Input transfected LSD1 wt 
Sur.(-) 
IP 
Ctrl              Transf.              Transf.        Transf. 
                    LSD1wt             S131A        S131E   
 
Fig. 30 
LSD1 complexes immunoprecipitation reveals the presence of CK2. 
 
WBs disclose the immunoprecipitation of several players of the LSD1 complexes. A little signal 
about the presence of CK2 in the complex is detected. The lacking of β-actin in IPs and the burned 
signals in the lanes of the surnatants (flash signal detected) confirm the proper washing and the 
trueness of the CK2 signals. 
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However, we cannot exclude that LSD1 phosphorylation of Ser131 plays 
a role as bait for other proteins not included in the test, indeed LSD1 
complexes contain many proteins and just a little portion of these are 
checked at date (Fig. 31).  
Although, we disclose that CK2 binds this complex, the identity of the 
protein which is responsible for this binding remains elusive.   
The unumbigous identification of this protein might help to explain how 
the phosphorylated CK2α is recruted by the complex.  
Indeed, in our hypothesys the phosphorylated C-terminal of CK2α plays 
an essential role in this biological process, managing the phosphorylation 
of LSD1.  
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Fig. 31 
Model of the interaction between CK2 and LSD1 complex 
A: Many players of this complex perform their own role by a physical interaction as well as CK2, but 
in contrast for this enzyme the binding seems instable. In fact, only a small amount of CK2 is co-
immunoprecipitated in comparison to  LSD1, Corest1 and HDAC2 (Fig.30). 
B: The LSD1 mutants Ser131Ala and Ser131Glu form a complex similar to the wild type one, but many 
players of this complex have not been analyzed [72, 85, 86].   
A 
 
 
 
 
 
 
 
 
 
 
B 
Regulation of LSD1 histone demethylase activity by its 
associated factors [86] 
Identification of LSD1-associated proteins. The LSD1-associated factors 
were purified using tandem tag affinity purification (Shi et al.,2003), 
separated on a 4%–12% gradient SDS NUPAGE gel, and visualized by silver 
staining. The identities of these proteins were revealed by MS/MS and 
indicated on the right. [86] 
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Fig. 32 
LSD1 complex phosphorylation by a co-immunoprecipitated kinase. 
A: IPs, resuspended in 50 mM Tris-HCl pH 8.0, 12 mM MgCl2, 20 μM [γ-33P]ATP (2000 cpm/pmol) in a 
total volume of 20 μl and incubated for 15’ at 30°C are phosphorylated by an endogenous kinase. WB 
reveals the identity of the main phosphorylated bands as LSD1.  
Furthermore WB analysis reveals that LSD1 are split in two bands. The upper one corresponds to a 
phosphorylated form of LSD1, while the lower one is the non-phosphorylated protein.  
B: LSD1 complex phosphorylation is inhibited by the CK2 inhibitor Cx4945. In the picture, IPs are 
phosphorylated by an endogenous kinase. The compound Cx4945 (30 nM) reduces the phosphorylation, 
confirming that the co-immunoprecipitated kinase is CK2. NB: In this experiment the phosphorylated band 
seems a doublet, but is an effect due to an unusual degradation of this sample.       
26A. Phosphorylation of the immunoprecipitated 
complex by co-immunoprecipitated CK2 
 
The endogenous CK2, immunoprecipitated by the flagged LSD1 is still 
enzymatically active, indeed radio-labeled ATP addiction to the 
immunoprecipitated pellet marks a single bands at about 120 KDa (Fig. 
32A). WB identifies the phosphorylated band as LSD1, but also an 
additional lower band, suggesting that the phosphorylation induces an quite 
altered migration in SDS-PAGE, which is detectable in this experimental 
condition (SDS PAGE with 6,5% of acrylamide) (Fig. 32A).   
The inhibition of the phosphorylation due to the CX4945 (30 nM), a 
selective inhibitor of CK2, confirms that this phosphorylation is due to CK2 
(Fig. 32B) and confirms the WB results (Fig.30).  
In the complex LSD1 appears as the main target of CK2, but many radio 
labeled bands are also identified, thus we cannot exclude that other proteins 
of this complex can be CK2 substrates (Fig.32B). 
 
 
 
 
 
 
 
 
 
 
 
 
~110 KDa 
~120 KDa 
A    B 
~50 KDa 
~120 KDa ~1 0 KDa 
~120 KDa 
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27. Co-occurrence of the LSD1 sub-domain 1-178 
and CK2 C-terminus in chordata. 
 
27A. Temporal evolution of LSD1, an additional domain is developed by 
chordata at the N-terminal segment. 
 
Similar to CK2α, LSD1 has an unfolded segment. This latter however is N-
terminal, while the one is C-terminal. Many hypotheses have been 
formulated regarding the role for this domain of LSD1, suggesting 
regulatory functions (e.g. sumoylation at a KxE motif [81]). The N-J 
phylogenetic tree reported below (Fig. 33) shows the temporal evolution of 
the Amine Oxidase catalytic Domain (AOD) and the "human like" N-
terminal domain. LSD1 N-terminal domain appeared later than the AOD 
domain in the evolution, suggesting an auxiliary role for this portion of 
LSD1. However, it is invariably conserved in all the chordata and moreover 
in several deuterostomes, suggesting that this portion of LSD1 is very 
important for these organisms and its evolution now is "crystallized". 
Furthermore, it is very interesting that the CK2 consensus motifs are 
invariably conserved in these organisms. 
Our data suggest the conservation of the AOD (AA 178-852 of sequence 
O60341 KDM1A_HUMAN) in all the species analyzed. Notably, LSD1 
homologues are found also in fungi and plants. 
Consistent with the idea of a unique clade collecting all the LSD1 sequences; 
LSD4 and Juji2A (two lysine specific demethylase; isozymes of LSD1) 
belong to a separate clade, as well as the root protein (Fig.33). 
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27B. LSD1 acquires a regulatory domain in its N-terminus in chordata 
 
Chordata (like Homo sapiens) show an additional domain at the N-terminus, 
which contains the three CK2 phosphorylation sites, generating the basis for 
a new regulatory network (Fig. 34). 
Remarkably, we reported (Fig.6B and Fig35) a similar evolution for the 
Cdk1 directed phosphosites on the CK2α C-terminal sequence. Indeed, the 
phospho acceptor sites were developed starting from the insects, and reached 
the "human like sequence" only in vertebrates. 
We hypothesize that CK2α C-terminus and LSD1 N-terminus domains 
appeared in the evolution starting from shorter enzymes (with only the 
catalytic domains), correlating these two enzymes into a common regulation 
strategy. Consistent with this, our experiments provide data about a 
functional relation between CK2 and LSD1, suggesting a preferential 
recognition of LSD1 by the phosphorylated CK2.   
These phosphorylated segments of LSD1 and CK2α are not essential for the 
catalytic events [49 and Chapter 11], suggesting that their functions are 
auxiliary for the cell and probably regulatory. 
We hypothesize that these two motifs allow an interaction between CK2 and 
LSD1 and play key role their recruitment in vivo in chordata (Fig. 35).  
Ancient organisms don't have this regulatory network, simply by the lacking 
of phospho-acceptor residues (Fig. 36). 
In chordata and in several deuterostomes, CK2 gains the C-terminus and the 
ability of co-localize to the mitotic spindle [36] and readily LSD1 gains the 
phosphorylable serines. Intriguingly, only these organisms showed to have 
bait/prey sequences, hence we can speculate that C-terminus region of CK2α 
is present to respond to a more complex mitosis and in general to a more 
complex cellular regulation. Furthermore, we speculate that other proteins 
are able to recognize the CK2α C-terminus, as well as LSD1, forming 
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Fig. 33 
Phylogenetic tree of the 22 LSD1 paralogous sequences.  
In the tree is reported the evolutive history of the protein LSD1. The catalytic core is highly conserved from 
plant to human, while an auxiliary N-terminal segment appears with the evolution of the chordata. The 
internal controls: LSD4 and Juji2A (two lysine specific demethylase; isozymes of LSD1) belonged to a 
separate clade, as well as the root protein, suggesting that the other sequences clusterize together in a 
group of paralogous proteins.    
 
 
 
                                
                               
          LSD1 N-terminus                       Amine oxidase domain (AOD) →   
Fig. 34 
Multialignment of LSD1 paralogous sequences reveals that the 
phosphoresidues lately appear in the evolution of LSD1 
(Focus on amino acids 120-260 of the human LSD1 O60341-KDM1A_HUMAN) 
 
In the picture, a little group of organisms have the consensus motifs for CK2 and phospho acceptor residues, 
while many proteins, having the AOD domain, don't show this portion of sequence. 
     
 
 
 
 
 
 
 
 
 
 
 
                                                              
              LSD1 N-terminus                       Amine oxidase domain (AOD) →   
"CK2α C-terminus specific" signaling cascades.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Development of the "human 
like" N-terminus 
(Phosphorylable by CK2) 
 
LSD4 and Juji2A belong to 
an another clade 
LSD1clade 
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Fig. 35 
Evolution of N-terminal domain of LSD1 suggests an acquired 
regulation through phosphorylation, while a similar evolution of the 
CK2α C-terminus suggests its involvement in this event, suggesting the 
existence of a new regulatory pathway.  
 
A: The relationship, linking the evolution of the N-terminal segment of LSD1 and the C-terminus of CK2α, 
is proposed. Indeed, organisms which have a phosphorylable CK2α invariably have an LSD1 protein with 
CK2 consensus motifs, such as showed in the multialignments (B and C). 
 
Fig. 36 
A regulatory pathway involving the CK2 phosphorylation and the phosphorylation of 
LSD1 is present in chordata but not in ancient organisms. 
 
The data of the Fig.35 are summarized. Only a little group of Animalia, have phosphorylable 
CK2, phosphorylable LSD1 and the hypothesized pathway.   
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       A 
 
 
 
 
 
 
B       C 
CK2α    LSD1 
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Conclusions 
 
28.  CK2α and LSD1 phosphorylations are involved in mitosis 
 
CK2α subunit contains four proline-directed phosphorylation sites located on 
the C-terminal tail, which are phosphorylated in cell progressing through 
normal mitosis by Cyclin dependent kinase 1 (Cdk1). These 
phosphorylations play an important role in regulating the function of CK2, 
considering that cell lines with transient expression of phospho-mimic 
mutant CK2αT344E/T360E/S362E/S370E (CK2α4E) show "mitotic 
catastrophe" [35, 36].  
Our data confirm this view and disclose the preferential phosphorylation of a 
few endogenous substrates by CK2α4E in comparison to wild type. One of 
these is the Lysine Specific histone Demethylase 1 (LSD1). CK2α4E is able 
to mime the phosphorylation of CK2α, suggesting that LSD1 is 
preferentially recognized by the phosphorylated form of CK2α, generating 
an essential step for a proper mitosis. LSD1, an important player of the 
epigenetic machinery, can either repress or activate target genes by 
catalyzing the demethylation at Lys 4 and 9 of H3 histone [56, 72], 
modulating gene transcription and forming functional centrosomes [69, 73]. 
LSD1 phosphorylation regulates the activity of LSD1, favoring the 
formation of "a proper" epigenetic status in the cell. Indeed, LSD1 
misregulation or the misregulation of the phosphorylation of CK2 lead to 
chromosomic instability [35, 69, 70], through the formation of a defective 
mitotic spindle. We propose a new signaling cascade composed by Cdk1, 
CK2 and LSD1, controlling methyl marks on the histone protein H3 (Fig. 
37). Moreover, the detection of CK2 in LSD1 complex suggests a new role 
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Fig. 37 
The regulatory pathway involving CK2, Cdk1 and LSD1. 
 
of CK2 as transcriptional modulator and as requirement for a proper mitosis.  
Mass spectrometry analysis reveals that LSD1 is phosphorylated at Ser131, 
Ser137 and Ser166, in the N-terminal domain. This region of LSD1 (1-178) 
is not crystallographically aviable, in contrast to the AOD domains (179-
852).  
Molecular modeling of this region suggests a metastable structured domain, 
thus CK2 phosphorylation might alter this structure, allowing the fine 
regulation of LSD1. 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
To note that only high eukaryotes like chordata have this pathway; indeed, 
non-chordata, plants and fungi do not have the phosphorylable domains in 
CK2α and in LSD1, in contrast to the catalytic domains which are invariably 
conserved. Taken together, these data suggest that high eukaryotes have 
acquired a new regulatory pathway, responding to a more complex mitosis 
and in general to a more complex cellular regulation.  
 
-Conclusions- 
  
       83 
 
  
 
29.  LSD1 Ser 131 phosphorylation modulates the transcription  
 
The existence in vivo of a functional interaction between LSD1 and CK2 is 
confirmed by the transfection of two mutants of LSD1, Ser131Ala and 
Ser131Glu, a phospho-defective and a phosphomimic mutant respectively. 
The expression of these mutated forms of LSD1 in HEK293T cells  has 
allowed to confirm the key-role of Ser131 phosphorylation as regulator for 
LSD1 in cells.  
In particular, mRNA level and the protein expression of the transcriptional 
factor FoxA2 is affected by the LSD1 Ser131Glu mutation, but remained 
unaltered when LSD1 Ser131Ala mutant is expressed, consistent with a 
relationship between  Ser131 phosphorylation and FoxA2 transcription. This 
regulation is gene-specific, indeed Pax6, a common target of LSD1, does not 
show a similar effect.  
Our data suggest that LSD1 Ser131Glu, but not the LSD1 Ser131Ala is able 
to repress the FoxA2 promoter in a specific manner.  
Currently, data about the methylation of the histone proteins near the FoxA2 
promoter are lacking, but several peculiar alterations seem predictable.    
The modulation of FoxA2 corroborates the hypothesis that LSD1 
phosphorylation is important during whole cell cycle (Fig. 38). In our 
hypothesis, a massive phosphorylation of LSD1 generates the modulation 
required during the mitosis, while a lower level of phosphorylation occurs in 
other events. Consistent with this, in addition to the Ser131 also the Ser137 
and the Ser166 are phosphorylated during the mitosis, thus we hypothesize 
that Ser131 phosphorylation effect will be enhanced in a synergistic way by 
the N-terminal tri-phosphorylation, allowing a pro-mitotic regulation. 
 
 
-Conclusions- 
  
       84 
 
  
 
 
Fig. 38 Scheme of action of LSD1 phosphorylation  
 
 
 
 
Consistently, a small amount of CK2 co-immunoprecitates during the whole 
cell cycle and the Ser131 phosphorylation is just sufficient to generate a 
phenotype.  
LSD1 phosphorylation may explain many paradoxal features of this protein. 
Indeed, no molecular mechanism accounts for selective demethylation of H3 
Lys4 or Lys9 by LSD1, two events displaying opposite biological functions 
[72] and the phosphorylation may provide an elegant explanation of this 
apparent contradiction. 
As useful complement of this hypothesis, we reported the inhibition of the 
LSD1 phosphorylation by polycations and by the histone subfraction f1, 
suggesting that CK2 phosphorylates LSD1 when is located in actively 
transcribed region of the chromatin. In this portion of the chromatin, the 
AA-122                                         AA-174 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AA-122                                  AA-174 
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histone proteins are generally neutralized by acetylations and CK2 is not 
repressed. On the other hand, CK2 fails the recognition of LSD1 when it 
binds heterochromatin, generating an essential complement for the gene 
regulation.  
In according to the modulation of FoxA2 by LSD1 Ser131 phosphorylation, 
also other mRNAs are modulated; indeed mRNAs of Corest2 and BMP2 are 
significantly increased by the LSD1 mutant Ser131Ala in comparison to the 
wt one, suggesting that LSD1 Ser131Ala is defective during the repression 
of the FoxA2, Corest2 and BMP2 genes.       
 
30.  LSD1 phosphorylation might be involved in the apoptosis, 
allowing chromatin condensation 
 
To note that, phosphorylation of LSD1 by CK2 may be involved in another 
event unrelated to the mitosis, in fact in the supplementary materials S5, we 
describe the phosphorylation of CK2 by the pro-apoptotic kinase HIPK2 
(homeo-domain interacting protein kinase 2). 
This suggests that CK2α phosphorylation may have a role in the apoptotic 
events. In effect an essential step of the apoptosis is the chromatin 
condensation in the peculiar half-moon appearance. CK2 and LSD1 may 
have a role in this event for many aspects similar to the mitosis. 
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Materials and Methods 
31. Phylogenetic analysis 
The phylogenesis of the proteins has been performed by N-J 
clusterization. ClustalX2 and TreeView have been used.    
The input sequences were collected by random sampling of sequences 
representative of almost all the species (databases: 
UniprotKB\Swissbank), excluding almost all hypothetical sequences of 
proteins (non reported in vivo).                
 
Proteins which belong the CK2α multialignment: 
 
 
 
 
 
 
 
 
 
NP_777060.2 NP_031814.2 
NP_001886.1 NP_777061.1 
NP_001100879.1 NP_001085109.1 
NP_001002164.1 NP_001887.1 
NP_001036956.1 NP_492811.1 
NP_524918 NP_001105486.1 
XP_623397 NP_179890.1 
EFX82799 BAB21589 
XP_785475.3 EFN62439.1 
X XP_002407929.1 
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Proteins, which belong the LSD1 multialignment: 
 
 
32. Bacterial cultures and recombinant protein 
purifications 
Liquid bacterial cultures were performed at 37°C for the routinely uses in LB medium 
(10 g/l NaCl, 10 g/l Tryptone, 5 g/l Yeast extract).  
Solid bacterial cultures were performed in LB medium / agar 15 g/L.  
Bacterial selection was performed by the addiction of ampicillin 100 ug/ml 
to the medium, in according to the resistance gene carried by the plasmid. 
  
Recombinant proteins inductions were performed by the addiction of 
IPTG 0.5 mM (Inalco cod.17581400) at 30°C for 4h in LB medium. 
Induction started at cellular 0.6 OD at 600 nm. In contrast, LSD1 expression 
was performed by the addiction of IPTG 0.2 mM (Inalco cod.17581400) at 
37°C for 6h in LB medium. 
  
NP_055828 BAC97980.1 
XP_002716073.1 XP_002811361.1 
XP_001272154.1 NP_001229924.1 
XP_001984247.1 NP_193364.5 
EFR26969.1 ABO32368.1 
XP_002265069.1 XP_002646136.1 
XP_612243.4 XP_002194853.1 
XP_001122201.2 EFX90178.1 
EGE77622.1 NP_055478.2 
XP_002410496.1 XP_003724297.1 
NP_001009999.1 XP_001816769.1 
JAA05976.1 NP_759014.2 
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Bacterial cell lysis was performed by sonication (PBI Sonic ruptor 400) 
(pulse 15'' at 40% of power),  60'' of incubation in ice between the pulses 
prevents over-heating. Six times were occurred to obtain a clear extract.  
The lysis buffer was 50 mM Tris HCl pH 8.5, 7 mM B-Mercaptoethanol, 
protease inhibitor Cocktail- EDTA free Roche mini was added (1 pill / 40 ml 
of buffer).   
 
Purification of recombinant proteins: 
 
CK2α-wt  
This protein was purified by GE-heparin Hi-trap column, collecting all 
cationic proteins in a gradient buffer 300mM Tris HCl pH 8.5, 0-1 M NaCl. 
A second step,  size exclusion G75 column GE-superdex-buffer 50 mM Tris 
HCl pH 7.5, 0.3 M NaCl, allowed the collection of the CK2α protein at 
homogeneity. 
     
CK2α-Δ1-336  
This protein was purified by  GE-heparin Hi-trap column, collecting all 
cationic proteins in a gradient buffer 50 mM Tris HCl pH 8.5, 0-1 M NaCl. 
This step allowed the collection of the CK2α-Δ1-336 protein with high grade 
of purification. 
 
CK2 β  
CK2β was purified by phosphocellulose column collecting by affinity, ATP 
binding proteins. A gradiented buffer 50 mM Tris HCl pH 8.5, 0-1.5 M NaCl 
released CK2β. A second step, size exclusion G75 column GE-superdex-
buffer 50 mM Tris HCl pH 7.5, 0.3 M NaCl, allowed the collection of the 
CK2β protein at homogeneity.  
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LSD1 (Plasmid was kindly provided by Shi Y.) 
His-tagged LSD1 was purified by nickel affinity column (GE-his Trap) 
collecting histidine rich proteins. A second step, size exclusion G200 column 
GE-superdex-buffer Tris HCl pH 7.5, 0.3 M NaCl, allowed the collection of 
the LSD1 protein with 90% of purity.  
 
 
33. Protein in vitro phosphorylation and kinase 
autophosphorylation 
 
33A.  Phosphorylation of synthetic peptide CK2-tide 
 
The synthetic peptide RRRADDSDDDDD was kindly provided by Dr. 
Oriano Marin. The lyophilized powder was resuspended in water and 
neutralized at pH 7 by 0.5 M NH3. 
The reaction is performed in buffer 50 mM Tris HCl pH 7.5, peptidic 
substrate 0.1 mM. 1 pmol of CK2α proteins were added to obtain an 
observable phosphorylation at 30°C for 10’. 
The reaction (27µl for tube) was started by 3µl of radio labeled [γ-33P]ATP 
(1000 cpm/pmol) 0.66 mM. 
The reaction was stopped by spotting on a phosphocellulose paper P81 (2cm 
x 2cm), the synthetic peptide was immobilized by affinity on the paper and 
radio labeled ATP was removed by washing.   
Each spotted paper was measured by scintillation (Packard 1500 tricarb 
liquid scintillator analyzer). Each sample was repeated twice.  
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33B.     CK2 auto-phosphorylation  
 
The reaction is performed in buffer Tris HCl pH 7.5 50 mM,  
2 pmol of CK2α proteins (and eventually 2-4 pmol of CK2β) were added to 
obtain an observable phosphorylation at 30°C for 10’. 50-100-200 mM NaCl 
could be added in according to the specific application. The reaction (17µl 
for tube) was started by 3µl of radio labeled [γ-33P]ATP (1000 cpm/pmol) 
0.66 mM. 
The reaction was stopped by the addiction of 10 µl of Laemmli buffer, and 
then was immediately subjected to SDS-Page 15%. The gel trapped the 
proteins, while the mix and the radio labeled ATP were discarded in running 
buffer. The dehydrated gel with radio labeled spots were imaged by a 
Cyclone phosphorImager system (Molecular Dynamics) and analyzed by 
OptiQuant software (Perkin Elmer). 
 
34. Human cells cultures  
The human neuroblastoma cell line SK-N-BE (SKNBE) and human 
embryonic kidney 293 transfectable cells (HEK293T) were cultured at 37°C 
with 5% CO2, in DMEM (Sigma Aldrich D5671) supplemented with 10% 
heat inactivated FBS (Sigma Aldrich F6178) and 1% PSG (Sigma Aldrich 
D6784). 
The cryopreservation of these cells was performed in liquid nitrogen and/or 
in freezer -86°C. The freezing medium was a mixture of 80% DMEM 
medium, 10% heat inactivated FBS and 10% DMSO.  
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35. Phosphorylation of cellular extracts in vitro 
 
SKNBE cells were cultured to reach 70–80% confluency and then lysed in a 
MAPK buffer containing 50 mM Tris, 150 mM NaCl, 0.5% Triton X-100 
with a cocktail of anti-proteases (Roche, Mannheim, Germany) and anti-
phosphatases (Sigma). After protein quantification, lysates corresponding to 
80 μg were incubated with radio labeled [γ-33P]ATP (2000 cpm/pmol) 20 
μM, 12 mM MgCl
2
, 45 mM NaCl. After 5' of incubation at 30°C, the 
reaction was stopped by 4 volume of 99%  ice-cold acetone.  
 
36. Separation by bi-dimensional gel electrophoresis 
of cellular extracts 
 
The phosphorylated reactions (stopped by 80% ice-cold acetone) were 
collected by precipitation at −80°C o/n, and spun down at 13000×g, 4°C for 
30', the supernatant was removed and the pellet was air dried. The pellet was 
then resuspended in a buffer containing 7 M urea, 2 M thiourea, 3% 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1% ampholyte (3–
10), and 40 mM Tris. Samples were reduced with 65 mM DTT for 1 h and 
then alkylated by 60 mM acrylamide for 1h. Isoelectrofocusing was 
performed on ReadyStrip IPG strips, 3-10NL. For the second dimension, the 
strips were equilibrated in 375 mM Tris (pH 8.8), 6 M urea, 20% glycerol 
and 2% sodium dodecyl sulphate for 30'. The strips were then run on 12% 
SDS-PAGE gels. Radioactive spots were imaged by a Cyclone 
PhosphorImager system (Molecular Dynamics) and analyzed by OptiQuant 
software (Perkin Elmer). After the detection, the spot were excided and 
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analyzed by MALDI TOF-TOF. 
 
37. Phosphorylation of the recombinant LSD1 by CK2 
in vitro 
 
The reaction was performed in buffer 50 mM Tris HCl pH 7.5, 1 pmol of 
CK2α proteins were added to obtain an observable phosphorylation at 30°C 
for 10’, eventually NaCl 40-230 mM could be added in according to the 
specific application.  
The reaction usually contains 400 ng of LSD1 (≈ 4.1 pmol), while for kinetic 
analysis, LSD1 phosphorylation was performed at concentrations between 0 
and 531.9 nM (0-1000 ng).  
The effect of CK2β on the LSD1 phosphorylation was checked by the 
addition of CK2 β (2-4-8 pmol), while the effect of the polycations was 
checked either by the presence of poly-L-lysine 0-1-3 μM (Sigma Aldrich 
p8920) or by the addition of the calf histone sub-fraction lysine rich f1 
(Sigma-Aldrich H1255) at the final volumes 0.6 and 1.2 µg/µl.   
The reaction (17 µl for tube) was started by 3µl of radio labeled [γ-33P]ATP 
(1000 cpm/pmol) 0.66 mM. 
The reaction was stopped by the addiction of 10 µl of Laemmli buffer, and 
then was immediately subjected to SDS-PAGE 10-15%. The gel trapped the 
proteins, while the mix and the radio labeled ATP were discarded in running 
buffer. The dehydrated gel with radio labeled spots were imaged by a 
Cyclone phosphorImager system (Molecular Dynamics) and analyzed by 
OptiQuant software (Perkin Elmer). 
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38. Lysis of cells (WB and IP) 
Cells recovery of SKNBE from culture flask was performed by 
Trypsin/EDTA (Sigma Aldrich T3924) and centrifugation, while HEK293T 
recovery by simple agitation and centrifugation. Cells were washed by PBS 
buffer 1 time.  
Cellular pellets were lysated by RIPA Buffer (PBS buffer 1X, 0.5% Na-
Deoxicolate, 1% NP40, 0.1% SDS and protease inhibitor Cocktail - EDTA 
free (Roche Cat. No 11873580001).   
The cells were harvested in ice for 30' and cells lysis has been ensured by 
pipetting. Finally, the lysates were centrifuged (18000×g, 20' at 4 °C) to 
separate cellular debris from the "crude extract". 
 
39. Proteins determinations by Bradford assay 
 900 µl of Bradford reagent (100 mg Coomassie G250, 50 ml Ethanol, 100 
ml phosphoric acid 85%, 850 ml H20) was added to 100 µl of H2O and 
sample. 
A standard calibration curve with BSA (bovine serum albumin) at known 
concentrations was prepared. 
Absorbance was detected by spectrophotometer (GE Genequant100) at 595 
nm and linear regression detects sample concentration.  
 
 
40. SDS-PAGE and Western blotting 
SDS-PAGE 
A discontinuous gel, consisting of a stacking and a running gel, was prepared 
to separate protein in a solid phase. 
Running Gel Composition: 6-15% Acrylamide (in according to the 
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application), 
H2O, 300 mM Tris HCl pH 8.8, 0.1% SDS, 0.05% APS (ammonium 
persulphate), 12 ul TEMED (N,N,N',N'-tetra-methylen-di-amine). 
Stacking Gel Composition 4% Acrylamide, H2O, 125 mM Tris HCl pH 6.8, 
0.1% SDS, 0.05% APS (ammonium persulphate), and 12 µl TEMED. 
The samples, consisting of phosphorylated reactions, recombinant proteins 
or 1- 20 µg of cellular lysates, were diluted in Laemmli buffer 3X (185 mM 
Tris/HCl pH 6.8, 6% SDS, 30% glycerol, 15% 2-mercaptoethanol, 0.01% 
pironin y). 
The electrophoresis was performed in 25 mM Tris/HCl, 19.2 mM glycine, 
0.1% SDS, at constant amperage of 25 mA.  
After running, proteins were stained by Commassie R/Ethanol/Acetic acid or 
transferred onto PVDF membrane. 
 
Western Blotting (WB) 
1-20 μg of proteins were transferred to a PVDF membrane Immobilon-P 
(Millipore IPVH00010) at 60V, for 30-90' in cold buffer (CAPs 2.02 g/L, 
methanol 1%, NaOH pH 10, 4-8°C).  
In order to saturate non specific binding sites, the membrane was incubated 
in methanol 99%  for 30'' and dried for 2-4 h a r.t.  Dried membrane was 
washed in H2O for 5' and then for 30' in TBS-1% BSA (50 mM Tris/HCl, 
0.15 M NaCl, pH 7.5, 1% BSA). 
The membrane ready for the immuno-staining was incubated from 2 hours to 
O/N with the primary antibodies, appropriately diluted in TBS 1% BSA (see 
below). Several antibodies  require over-night incubation. 
The membranes were washed 3 times for 10' in TBS. Then, the membrane 
was incubated for 20' in presence of the secondary antibody conjugated with 
peroxides HRP (Perkin Elmer NEF812001EA; anti-mouse or anti-rabbit) 
diluted (1/4000) in TBS 1% BSA. 
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Following the final wash, the membranes were incubated in luminol/H2O2 
for several seconds and the detection of the antibody complex was 
performed by the Kodak Image Station 4000MM-Pro. 
 
The following primary antibodies were used: 
 
Code  Company Target Dilution 
X House made CK2α 1/1000 
A300215 Bethyl Pan-LSD1 1/9000 
F3165 Sigma-Aldrich Flag-LSD1 1/5000 
A301710 Bethyl ZNF198 1/1000 
07455 Millipore Corest1 1/1000 
s9959 Santa Cruz HDAC2 1/1000 
S8035 Santa Cruz Tubulin-α 1/5000 
C0603 Santa Cruz Β-Actin 1/5000 
Ab10474 Abcam CK2α' 1/1000 
AF2400 R&D systems FoxA2 1/1000 
F0208 Santa Cruz Β-Lamin 1/1000 
 
 
 
 
 
 
 
 
-Materials and Methods 
  
       97 
 
  
 
41. Dephosphorylation of LSD1 by calf intestinal 
phosphatase 
 
Lysates of Neuroblastoma SKNBE Cells (10 μg) was de-phosphorylated by 
100 U of Calf Intestinal Phosphatase (CIP) for 1h at 30°C and 
immunoblotted. For a direct comparison, an equal amount of lysate was 
treated in absence of the CIP enzyme for 1h at 30°C and furthermore an 
another sample was incubated in ice. 
SDS-PAGE and WB have been performed and the molecular weight was 
detected by an antibody. Notably, a low concentration SDS-PAGE gel has 
been used (polyacrylamide 6%), resolving proteins with high molecular 
weights.    
 
 
42. Mutagenesis of pTP6_Ko-FLAG/LSD1wt to 
Ser131Ala and Ser131Glu 
 
pTP6_Ko-FLAG/LSD1wt kindly provided by Dr. A. Adamo of the CMRB 
institute of Barcelona. 
Mutagenic primers Ala131for, Ala131Rev, Ala137for, Ala137Rev were 
purchased by Sigma Aldrich and mutagenic primers Glu131for, Glu131Rev, 
Glu137for, Glu137Rev were purchased by Invitrogen Custom synthesis. 
Quick change PCRs were performer in according to the protocol proposed 
by Stratagene for the kit (QuickChange® Site-Directed Mutagenesis Kit). 
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1-Reaction:  
 5 μl of 10× reaction buffer 
 50 ng of dsDNA template 
 125 ng of oligonucleotide primer #1 
 125 ng of oligonucleotide primer #2 
 1 μl of dNTP mix 
 ddH2O to a final volume of 50 µl 
 Then add 1μl of PfuTurbo DNA polymerase (2.5 U/μl) 
 
2-PCR 
Segment  Cycles  Temperature  Time 
1   1  95°C   30''  
 
    95°C   30'' 
2  18 55°C   1'  
   68°C  10'  
 
 
 
 
3-Digestion of the parental DNA and Bacterial Transformation 
  
 Add 1μl of the Dpn I restriction enzyme (10 U/µl) directly to each 
amplification and immediately incubate each reaction at 37°C for 1 
hour 
 Transfer 1 and 10 μl of the Dpn I-treated DNA from each sample to 
separate aliquots of the supercompetent cells 50μl. 
 Swirl the transformation reactions gently to mix and incubate the 
reactions on ice for 30'. 
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 Heat pulse the transformation reactions for 45 seconds at 42°C and 
then 
 Place the reactions on ice for 2' (note: This heat pulse has been 
optimized for transformation in 14-ml BD Falcon polypropylene 
round-bottom tubes). 
 
4 couples of primers were used: 
 
 
a. Ser131Glu  
Ser131Glu1° for: 
5'-gagagatggatgaaagcttggccaacctcg-3' 
Ser131Glu1° rev: 
5'-ctcatcttcttcgaggttggccaagctttc-3' 
 
b. Ser131Ala 
Ser131Ala1° for: 
5'-gatggatgaaagcttggccaacctcgcagaagatgag-3' 
Ser131Ala1° rev: 
5'-ctcatcttctgcgaggttggccaagctttcatccatc-3' 
 
c. Ser137Glu 
Ser137Glu2° for: 
5'-ggccaacctctcagaagatgagtattatga-3' 
Ser137Glu2° rev: 
5'-ctctcttcttcttcataatactcatcttct-3' 
 
d. Ser137Ala  
Ser137Ala2° for: 
5'-ggccaacctctcagaagatgagtattatgcagaagaagagag-3' 
-Materials and Methods 
  
       100 
 
  
 
Ser137Ala2° rev: 
5'-ctctcttcttctgcataatactcatcttctgagaggttggcc-3' 
 
Quick change PCRs failed anytime, and an alternative strategy has been 
performed by molecular cloning. 
The mutagenic cloning were performed by a first mutagenic step through 
PCR, and then by the transfer (restriction and ligation) of the mutations in 
the final vector pTP6_Ko-FLAG/LSD1.     
 
Mutagenic PCRs 
 
Segment  Cycles  Temperature  Time 
1   1  95°C  30 seconds 
 
    95°C  30''  
2  25 53°C  30''  
   72°C 60''  
3  1 72°C 5'   
 
 
Primers for the mutation Ser131Glu: 
Ser131Glu1° for: 
5'-gagagatggatgaaagcttggccaacctcg-3' 
LSD1Exon8rev 
5'-tttctctttaggaacagcttg-3'  
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Primer for the mutation Ser131Ala: 
 
Ser131Ala1° for: 
5'-gatggatgaaagcttggccaacctcgcagaagatgag-3' 
LSD1Exon8rev 
5'-tttctctttaggaacagcttg-3'  
 
 
 
 High fidelity Fusion Polymerase (NEB Cat. No M0530L) and 5 ng of the 
vectors pTP6_Ko-FLAG/LSD1wt was used in each reaction. 
About 1µg of PCR products were obtained by gel extraction (QIAquick Gel 
Extraction Kit Cat. No: 28704) from the reaction Ser131Ala and Ser131Glu. 
DNAs were restricted by the HINDIII endonuclease (NEB Cat. No R0104L)  
(1Unit) in Buffer3 (NEB) for 2 hours at 37°C, the purified fragment was 
obtained and ligated by T4 ligase (NEB Cat. No M0202L) into the HINDIII 
pre-digested vector pGEMt-EASY LSD1 at 16°C O/N. 
Then, the mutated gene was cutted by the BSPEI and AGEI endonucleases, 
producing a fragment containing either by the mutation Ser131Ala or 
Ser131Glu. These fragments (purified by gel extractions) were ligated into 
two vectors pTP6_Ko-FLAG/LSD1 (digested with the same enzymes). The 
complete sequencing of the mutated genes (S131E and S131A) confirmed 
the mutations. 
 
43. Transfection of HEK293T cells  
 
Two day before, 1.5x10
6 
HEK293T were seeded in 10 cm dish. The 
exogenous DNA represented by 5µg of the eukaryotic vectors pTP6_Ko-
FLAG/LSD1wt, pTP6_Ko-FLAG/LSD1Ser131Ala, and pTP6_Ko-
FLAG/LSD1Ser131Glu were linearized by the restriction enzyme ScaI 
(NEB Cat. No R0122L) in Buffer3 (NEB) O/N at 37°C.    
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After this stage, each DNA has been incubated with 10 μl of transfection 
reagent FuGENE6 (ROCHE Cat. No 11815091001) at r.t. for 5’ and then 
with 500 μl of OptiMEM medium without FBS for 25’. 
Each mix was added to the dish (confluency 60-80%). The culture was 
incubated for 24 hours, at 37°C, 5% CO2, and then the transfection medium 
was replaced by fresh medium.  
Selection of transfected cells was carried out by three treatments of 
puromycin (Sigma Aldrich Cat. No F8833); the treatments were carried out 
by increasing concentrations (1 day 0.1 μg/ml, 2 days 0.3 μg/ml, 2 days  1 
μg/ml) .  
The expression of the exogenous LSD1 was detected by WB against the N-
terminal Flag (ϟDYKDDDDKϟ) and by another epitope. Stable expression 
was assumed after 10 day, starting from the DNA transfection.   
 
 
44. mRNAs extraction and Real time PCR 
 
Approximately 400 µl of cellular pellet, obtained by scraping and 
centrifugation (250g, 5', 25 °C) were dissolved in 1 ml Trizol 
(GibcoBRL/Life Technologies). Then, 0.2 ml of chloroform was added and a 
briefly mixing was done. The suspension was centrifuged at 15 000xg for 10' 
at 4°C. The upper phase (solvent: chloroform) was recovered. RNA 
precipitation is performed by the addition of an equal amount of isopropanol 
100%, incubation in ice and centrifugation allow to observe a little pellet on 
the bottom of the eppendorf. The pellet was washed by 750 ul of 
Ethanol/DEPC water 3:1 (Ethanol 75%), centrifugated, recovered and dried 
at room temperature in top-less eppendorf. Finally, the air dried pellet was 
dissolved in 50 µl of DEPC water.  
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RNA was quantify by NanoDrop technology (NanoDrop 1000 Spectro-
photometer Thermofisher scientific) and stored at -80°C.  
 
44A.  mRNAs reverse-transcription 
1 ug of mRNA of each sample or treatment was converted to cDNA by 
reverse-transcription in according to proposed protocol. (Cloned AMV first 
strand synthesis kit-Invitrogen Life technology). 
 
44B. Quantification by Realtime PCR  
mRNA levels were quantified by real-time PCR using SYBR Green and are represented 
relative to GAPDH (glyceraldehyde 3-phosphate dehydrogenase) expression. For a direct 
comparison of the cell lines, mRNA levels are divided to the amount of the specific 
mRNA in the control cell (value = 1), thus each value is a ratio.  
Each reaction contains 0,1 μl of cDNA, 1 μl of forward primer (10 μM), 1 μl of reverse 
primer (10 μM), 10 μl of Sybr-green master mix (Life technology) and 7.9 μl of H2O. 
 
 The sequences of oligonucleotides used for quantitative PCR (qPCR) are listed below: 
 
BMP2-F 5’-CCAACACTGTGCGCAGCTT-3’ 
BMP2-R 5’-CCCACTCGTTTCTGGTAGTTCTTC-3’ 
PAX6-F 5’-GCTTCACCATGGCAAATAACC-3’ 
PAX6-R 5’-GGCAGCATGCAGGAGTATGA-3’ 
FOX2-F 5’-CTGAAGCCGGAACACCACTAC-3’ 
FOX2-R 5’-CGAGGACATGAGGTTGTTGATG-3’ 
RCO2-F 5'-TCCCTGACGAGTGGACAGTAGAG-3' 
RCO2-R 5'-TGCCATGGAAGCCAAA-3' 
ZNF1-F 5'-TGCTGTCAAAGTTGTGTCAGTGA-3' 
ZNF1-R 5'-CCTCCTTCAGGAAGCTTGGA-3' 
CK2B-F 5'-ACTGTGAGAACCAGCCAATGC-3' 
CK2B-R 5'-ATGGCTTCACCTGGGATGTC-3' 
GAP-F 5'-CCAGCCGAGCCACATCGCT-3' 
GAP-R 5'-ATGAGCCCAGCCTTCTCCAT-3' 
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45. Nuclear and cytoplasmic subfractionation 
The buffer 10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM 
DTT, 0.01% NP40 (500µl) was added to a large petri dish (125cm
2
) on ice 
and a thorough scraping was performed. Cells have been incubated in ice for 
10' and then centrifuged at 4°C at 3000 rpm for 10'. The supernatant was the 
cytoplasmatic fraction. The pellet was resuspended in 500 µl of RIPA buffer 
and homogenized by Dounce. After 30' of incubation, the mix was 
centrifuged at 18000xg for 20' at 4°C. The clear extract has been considered 
as the nuclear extract.  
 
 
46. Immunoprecipitation 
500 μg of protein lysates in RIPA buffer (PBS buffer 1X, 0.5% Na-
Deoxicolate, 1% NP40, 0.1% SDS, Protease inhibitor Cocktail - EDTA free 
Roche mini) were incubated for 4 h at 4°C in agitation, then 15μl of anti-
FLAG Ig beads/PBS1:1 (Sigma Aldrich A2220) were added to the mix. The 
binding has been performed for 30' at 4°C by agitation.   
Beads were collected by centrifugation at 1000xg for 3' at 4°C, while the 
surnatant were placed in a new tube.    
Beads were washed 3 times in 1 ml of PBS (5' rocking agitation) and then 
spun down by centrifugation at 1000xg for 3' at 4°C.  
The final pellet of beads was suspended in non-reducing Laemmli buffer and 
subjected in SDS-PAGE to separate proteins. Heating at 95°C for 5' of the 
pellet allowed the complete rescuing of the immunoprecipitated proteins.   
Finally, WBs were performed to detect co-immunoprecipitates proteins. 
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Supplementary materials 
 
S1.  Expression and purification of recombinant 
CK2α subunit and its mutated forms Δ1-336 and 
CK2α-4E     
 
 CK2α-Δ1-336       
Theorical MW (Protparam prediction): 40 KDa (≈) 
Theorical pI: 7.0 
 
The induction and the purification of CK2α-Δ1-336 were done and a 
good yield of purification has been reached by Heparin Anionic 
Exchanger, in the figure 39 are reported all the steps of the purification.  
 
Fig. 39  Purification of CK2α-Δ1-336 
In this coomassie stained SDS-PAGE, they are reported all the steps of the purification. The white 
arrows show the final result of the purification of CK2α-Δ1-336.  
 
 
The fractions 33-36 have been dialyzed with a semi-permeable 
membrane in 25mM Tris-HCl buffer  pH 7.5, Glycerol 50%. 
3 ml of CK2α-Δ1-336 at concentration of 2.35mg/ml has been obtained.  
 
 Input      Pellet    Flow-through  Washing        Fz.30         Fz.33         Fz.36         Fz.39        Fz.42          
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 CK2α-wt       
Theorical MW (Protparam prediction): 45 KDa (≈) 
Theorical pI: 7.3 
 
CK2α-wt purification is reported in the following image (Fig. 40), 
furthermore the induction and the purification by Heparin Anionic 
Exchanger are observable. 
 
Fig. 40 Purification of CK2α-wt 
In this coomassie stained SDS-PAGE, they are reported several steps of the purification. The white 
arrows show the intermediate of purification of CK2α-wt.  
 
 
The fractions 24-26 have been loaded in the G75 superdex 26/60 a size 
exclusion chromatographic column to separate CK2α-wt from other 
undesirable proteins. In the figure 41 is reported the final fractionation of 
CK2α-wt. The undesired and spontaneous degradation of CK2α-wt 
(fractions >84) is also observable. Size exclusion allowed to enrich the 
full-length protein and discard the degradation product 1-330(≈), 
unfortunately during this process a big amount of CK2α-wt were lost. 
The yield of the process was less than 50%. 
 
 
                   Input    Flow-through   Washing       Fz.24           Fz.26            Fz.28            Fz.30       
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Fig. 41  Purification of CK2α-wt 
In these two coomassie stained SDS-PAGEs, they are reported several steps of the purification. The 
white arrows show final result of the purification of CK2α-wt.  
 
 
 
The fractions 66-78 have been concentrated by Amicon membrane (Cut-
off 10 KDa and 0.2 ml of CK2α-wt at concentration 10 mg/ml has been 
obtained.  
 
 CK2α-4E     
Theorical MW (Protparam prediction): 45 KDa  
(Observed: 50 KDa) 
 
Theorical pI: 7.3 
 
CK2α-4E protein was kindly provided by Dr. Lolli G. Expression and 
purification were performed, following a protocol quite similar respect to 
CK2α-wt. CK2α-4E is a tetra mutant form of CK2α with the four 
substitutions, Thr344Glu, Thr360Glu, Ser360 and Ser370Glu. 
In the image (Fig. 42) are reported the final results of the three 
purifications (CK2α-wt, CK2α4E and CK2α-Δ1-336) analyzed by SDS-
PAGE (commassie stained). 
 
     Input  Fz.66    69      72          75        78         81        84          87         90          93       96          99       102         105       108        111        114       117                                                                                                                                
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Fig. 42  Summary of the three forms of CK2α obtained 
 
In this coomassie stained SDS-PAGE, purified forms of CK2α: Wt, mutant 4E, c-terminal truncated 1-
336 form, respectively lane 1, 2 and 3.  
 
 
 
 
In the first lane is reported the commassie staining of CK2α-wt and an 
undesired and spontaneous degradation, probably the ratio between full-
length forms vs. degraded form is 90%. Also CK2α4E undergoes to a 
spontaneous degradation, but in this case, it seems a little percentage.  
The third lane represents CK2α-Δ1-336. It is the stable form of CK2 and 
it has a very clear profile. The three enzymes have good and comparable 
yield of purity. 
 
 
 
 
 
 
 
 
 
 
   CK2α-wt       CK2α4E    CK2α-Δ1-336) 
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S2. Stimulatory effect of Poly-L-lysine in CK2α 
autophosphorylation 
 
To better understand the CK2α-4E  autophosphorylation in presence of 
CK2β and in particular to shed light on the role of CK2 α-β interaction in 
this process, we performed an experiment of stimulation by Poly-L-
lysine (Fig. 43). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
100 nM poly-L-lysine stimulates significatively CK2α-4E 
autophosphorylation, while it represses CK2β autophosphorylation.  
Strong basic proteins (e.g. histone proteins) might exert a similar effect 
CK2 α-wt CK2 α-4E 
Poly-L-lysine stimulation (100 nM) 
CK2β  (2-4-4 pmol) 
Commassie staining  
Phosphorimager (Autoradiography) 
= CK2 α-4E autophosphorylation vs. CK2 α-wt autophosphorylation (in presence of CK2β) 
= Poly-L-lysine 100 nM stimulates CK2 α-4E autophosphorylation   
CK2 α-Δ1-336  (2 pmol) 
Fig. 43: 
Stimulatory effect of Poly-L-lysine 
in CK2α autophosphorylation 
 
the coomassie stained SDS-PAGE shows similar 
amounts of enzyme, while the autoradiographic 
profile suggests an increased autophosphorylation in  
the mutant CK2α4E. Furthermore poly-L-lysine 
stimulate this autophosphorylation.   
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on the autophosphorylation, further suggesting the occurrence of Ser357 
autophosphorylation in vivo. Indeed, CK2 phosphorylation by Cyclin 
dependent kinase 1 (Cdk1) leads to the accumulation of CK2 in the 
mitotic spindle, subsequently CK2 conjugated to histone particles 
generates an "hot spot" of activity due to the interaction. 
In summary, the mutant CK2α-4E (or the phosphorylated CK2α in vivo) 
gains a good putative autophosphorylation site. The Ser357 could be 
quickly phosphorylated when supported by the mutated residues (or 
phospho-residues) and by the high concentration of histone proteins. 
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S3: Mass spectrometry characterization of the CK2 
phosphorylation profiles 
 
2D separation of a total soluble cellular extracts derived from human 
neuroblastoma cells (SK-N-BE) phosphorylated by either CK2α4E or 
CK2αwt reveals many phosphorylated spots. Nine radio labeled spots 
were excided and analyzed by mass spectrometry. The image discloses 
the position (Fig. 44) of the spots and the table (Tab. S3) the identity of 
the phosphorylated proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SPOT 01 
    
prot_acc prot_desc score mass matches 
GBLP_BOVIN 
Guanine nucleotide-binding protein subunit beta-2-like 1 OS=Bos taurus 
GN=GNB2L1 PE=2 SV=3 
510 35623 30 
ETFA_HUMAN 
Electron transfer flavoprotein subunit alpha, mitochondrial OS=Homo sapiens 
GN=ETFA PE=1 SV=1 
330 35484 11 
SFRS1_BOVIN Splicing factor, arginine/serine-rich 1 OS=Bos taurus GN=SFRS1 PE=2 SV=1 238 27870 10 
RS3_BOVIN 40S ribosomal protein S3 OS=Bos taurus GN=RPS3 PE=2 SV=1 227 26885 9 
EFTS_HUMAN Elongation factor Ts, mitochondrial OS=Homo sapiens GN=TSFM PE=1 SV=2 225 35794 10 
ARPC2_BOVIN 
Actin-related protein 2/3 complex subunit 2 OS=Bos taurus GN=ARPC2 PE=1 
SV=1 
195 34470 8 
CDK1_BOVIN Cell division protein kinase 1 OS=Bos taurus GN=CDK1 PE=2 SV=2 192 34075 9 
PIPNB_BOVIN 
Phosphatidylinositol transfer protein beta isoform OS=Bos taurus GN=PITPNB 
PE=1 SV=3 
143 31874 4 
ESTD_HUMAN S-formylglutathione hydrolase OS=Homo sapiens GN=ESD PE=1 SV=2 141 32082 9 
P5CR1_HUMAN 
Pyrroline-5-carboxylate reductase 1, mitochondrial OS=Homo sapiens 
GN=PYCR1 PE=1 SV=2 
139 33624 6 
CASP3_HUMAN Caspase-3 OS=Homo sapiens GN=CASP3 PE=1 SV=2 131 32156 5 
ISOC1_BOVIN 
Isochorismatase domain-containing protein 1 OS=Bos taurus GN=ISOC1 PE=2 
SV=1 
128 32450 4 
RM01_HUMAN 
39S ribosomal protein L1, mitochondrial OS=Homo sapiens GN=MRPL1 PE=1 
SV=2 
119 37170 6 
GNPI1_HUMAN 
Glucosamine-6-phosphate isomerase 1 OS=Homo sapiens GN=GNPDA1 PE=1 
SV=1 
117 32861 5 
                    9    8 
    7 
 
 
 
 
 
             6 
 
                  5                4    3 
 
       1           2 
CK2αwt 
CK2α4E 
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VDAC1_BOVIN 
Voltage-dependent anion-selective channel protein 1 OS=Bos taurus GN=VDAC1 
PE=1 SV=3 
107 30864 4 
VATE1_BOVIN V-type proton ATPase subunit E 1 OS=Bos taurus GN=ATP6V1E1 PE=2 SV=1 102 26194 4 
TRYP_PIG Trypsin OS=Sus scrofa PE=1 SV=1 102 25246 7 
HCDH_HUMAN 
Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial OS=Homo sapiens 
GN=HADH PE=1 SV=2 
93 34327 4 
SFR2B_HUMAN 
Splicing factor, arginine/serine-rich 2B OS=Homo sapiens GN=SFRS2B PE=1 
SV=1 
82 32410 3 
PHB2_HUMAN Prohibitin-2 OS=Homo sapiens GN=PHB2 PE=1 SV=2 74 33276 2 
VDAC2_BOVIN 
Voltage-dependent anion-selective channel protein 2 OS=Bos taurus GN=VDAC2 
PE=2 SV=2 
69 32239 3 
DECR_HUMAN 
2,4-dienoyl-CoA reductase, mitochondrial OS=Homo sapiens GN=DECR1 PE=1 
SV=1 
65 36400 2 
TATD1_HUMAN 
Putative deoxyribonuclease TATDN1 OS=Homo sapiens GN=TATDN1 PE=1 
SV=2 
54 34290 2 
     
SPOT 02 
    
prot_acc prot_desc score mass matches 
PSA1_HUMAN Proteasome subunit alpha type-1 OS=Homo sapiens GN=PSMA1 PE=1 SV=1 466 29892 31 
SFRS1_BOVIN Splicing factor, arginine/serine-rich 1 OS=Bos taurus GN=SFRS1 PE=2 SV=1 288 27870 11 
PGES2_HUMAN Prostaglandin E synthase 2 OS=Homo sapiens GN=PTGES2 PE=1 SV=1 191 42130 7 
NIT2_HUMAN Omega-amidase NIT2 OS=Homo sapiens GN=NIT2 PE=1 SV=1 175 31086 7 
CDK1_BOVIN Cell division protein kinase 1 OS=Bos taurus GN=CDK1 PE=2 SV=2 163 34075 6 
PROSC_HUMAN 
Proline synthase co-transcribed bacterial homolog protein OS=Homo sapiens 
GN=PROSC PE=1 SV=1 
149 30680 7 
PSA4_BOVIN Proteasome subunit alpha type-4 OS=Bos taurus GN=PSMA4 PE=1 SV=1 148 29820 8 
PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens GN=PNP PE=1 SV=2 143 32381 8 
EXOS6_HUMAN 
Exosome complex exonuclease MTR3 OS=Homo sapiens GN=EXOSC6 PE=1 
SV=1 
135 28573 6 
SFRS2_BOVIN Splicing factor, arginine/serine-rich 2 OS=Bos taurus GN=SFRS2 PE=2 SV=3 133 25461 6 
VATE1_BOVIN V-type proton ATPase subunit E 1 OS=Bos taurus GN=ATP6V1E1 PE=2 SV=1 123 26194 4 
TRYP_PIG Trypsin OS=Sus scrofa PE=1 SV=1 111 25246 9 
UCK2_HUMAN Uridine-cytidine kinase 2 OS=Homo sapiens GN=UCK2 PE=1 SV=1 91 29494 4 
SFRS7_BOVIN Splicing factor, arginine/serine-rich 7 OS=Bos taurus GN=SFRS7 PE=2 SV=1 84 27209 3 
RS3_BOVIN 40S ribosomal protein S3 OS=Bos taurus GN=RPS3 PE=2 SV=1 77 26885 2 
CDK5_BOVIN Cell division protein kinase 5 OS=Bos taurus GN=CDK5 PE=1 SV=2 71 33836 2 
IF4H_HUMAN 
Eukaryotic translation initiation factor 4H OS=Homo sapiens GN=EIF4H PE=1 
SV=5 
65 27439 2 
ECH1_HUMAN 
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial OS=Homo sapiens 
GN=ECH1 PE=1 SV=2 
63 36220 2 
EI2BA_HUMAN 
Translation initiation factor eIF-2B subunit alpha OS=Homo sapiens GN=EIF2B1 
PE=1 SV=1 
62 34046 2 
K1C9_CANFA Keratin, type I cytoskeletal 9 OS=Canis familiaris GN=KRT9 PE=3 SV=1 58 77161 2 
     
SPOT 03 
    
prot_acc prot_desc score mass matches 
IF2A_HUMAN 
Eukaryotic translation initiation factor 2 subunit 1 OS=Homo sapiens GN=EIF2S1 
PE=1 SV=3 
473 36445 26 
PURB_HUMAN 
Transcriptional activator protein Pur-beta OS=Homo sapiens GN=PURB PE=1 
SV=3 
318 33434 11 
UCHL5_HUMAN 
Ubiquitin carboxyl-terminal hydrolase isozyme L5 OS=Homo sapiens 
GN=UCHL5 PE=1 SV=3 
314 37938 16 
TCAL4_HUMAN 
Transcription elongation factor A protein-like 4 OS=Homo sapiens GN=TCEAL4 
PE=1 SV=2 
259 24774 9 
SEC13_HUMAN Protein SEC13 homolog OS=Homo sapiens GN=SEC13 PE=1 SV=3 255 36157 12 
TRYP_PIG Trypsin OS=Sus scrofa PE=1 SV=1 159 25246 11 
NMI_HUMAN N-myc-interactor OS=Homo sapiens GN=NMI PE=1 SV=2 131 35248 6 
FPPS_HUMAN Farnesyl pyrophosphate synthase OS=Homo sapiens GN=FDPS PE=1 SV=4 118 48884 5 
TBA1A_CRIGR Tubulin alpha-1A chain OS=Cricetulus griseus GN=TUBA1A PE=2 SV=1 91 50956 3 
KCD12_HUMAN 
BTB/POZ domain-containing protein KCTD12 OS=Homo sapiens GN=KCTD12 
PE=1 SV=1 
88 36034 3 
HNRPC_HUMAN 
Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiens 
GN=HNRNPC PE=1 SV=4 
85 33721 4 
CE051_HUMAN UPF0600 protein C5orf51 OS=Homo sapiens GN=C5orf51 PE=1 SV=1 80 34380 3 
PP2AB_BOVIN 
Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform OS=Bos 
taurus GN=PPP2CB PE=2 SV=1 
66 36249 3 
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SPOT 04 
    
prot_acc prot_desc score mass matches 
GLRX3_HUMAN Glutaredoxin-3 OS=Homo sapiens GN=GLRX3 PE=1 SV=2 363 37763 20 
K2C1_HUMAN Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 302 66212 12 
UCHL5_HUMAN 
Ubiquitin carboxyl-terminal hydrolase isozyme L5 OS=Homo sapiens 
GN=UCHL5 PE=1 SV=3 
302 37938 13 
PURB_HUMAN 
Transcriptional activator protein Pur-beta OS=Homo sapiens GN=PURB PE=1 
SV=3 
270 33434 9 
ODBB_HUMAN 
2-oxoisovalerate dehydrogenase subunit beta, mitochondrial OS=Homo sapiens 
GN=BCKDHB PE=1 SV=2 
221 43947 9 
CRK_HUMAN Adapter molecule crk OS=Homo sapiens GN=CRK PE=1 SV=2 206 33881 8 
DPH5_HUMAN Diphthine synthase OS=Homo sapiens GN=DPH5 PE=1 SV=2 171 32057 9 
SNAG_BOVIN Gamma-soluble NSF attachment protein OS=Bos taurus GN=NAPG PE=1 SV=3 170 35041 7 
K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 164 62311 6 
TRYP_PIG Trypsin OS=Sus scrofa PE=1 SV=1 106 25246 10 
     
SPOT 05 
    
prot_acc prot_desc score mass matches 
MTNA_HUMAN 
Methylthioribose-1-phosphate isomerase OS=Homo sapiens GN=MRI1 PE=1 
SV=1 
345 39552 14 
RFC2_HUMAN Replication factor C subunit 2 OS=Homo sapiens GN=RFC2 PE=1 SV=3 284 39700 11 
TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 202 45138 8 
VTA1_BOVIN 
Vacuolar protein sorting-associated protein VTA1 homolog OS=Bos taurus 
GN=VTA1 PE=2 SV=1 
182 34279 13 
HNRPK_BOVIN 
Heterogeneous nuclear ribonucleoprotein K OS=Bos taurus GN=HNRNPK PE=2 
SV=1 
162 51343 6 
UBCP1_BOVIN 
Ubiquitin-like domain-containing CTD phosphatase 1 OS=Bos taurus 
GN=UBLCP1 PE=2 SV=1 
162 36852 8 
ROAA_MOUSE 
Heterogeneous nuclear ribonucleoprotein A/B OS=Mus musculus GN=Hnrnpab 
PE=1 SV=1 
157 30954 6 
AS3MT_HUMAN Arsenite methyltransferase OS=Homo sapiens GN=AS3MT PE=1 SV=3 124 42716 6 
TRYP_PIG Trypsin OS=Sus scrofa PE=1 SV=1 108 25246 9 
ILEU_HUMAN Leukocyte elastase inhibitor OS=Homo sapiens GN=SERPINB1 PE=1 SV=1 101 42857 3 
PTPA_BOVIN 
Serine/threonine-protein phosphatase 2A activator OS=Bos taurus GN=PPP2R4 
PE=2 SV=1 
54 37285 2 
     
SPOT 06 
    
prot_acc prot_desc score mass matches 
GANAB_HUMAN Neutral alpha-glucosidase AB OS=Homo sapiens GN=GANAB PE=1 SV=3 816 107375 46 
HGS_HUMAN 
Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Homo sapiens 
GN=HGS PE=1 SV=1 
511 86848 21 
K2C1_HUMAN Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 458 66212 18 
KDM1A_HUMAN 
Lysine-specific histone demethylase 1A OS=Homo sapiens GN=KDM1A PE=1 
SV=2 
314 93484 13 
K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 254 59076 10 
HS74L_HUMAN Heat shock 70 kDa protein 4L OS=Homo sapiens GN=HSPA4L PE=1 SV=2 251 95705 8 
ALBU_BOVIN Serum albumin OS=Bos taurus GN=ALB PE=1 SV=4 198 71735 8 
TRYP_PIG Trypsin OS=Sus scrofa PE=1 SV=1 169 25246 12 
OGDHL_HUMAN 
2-oxoglutarate dehydrogenase-like, mitochondrial OS=Homo sapiens 
GN=OGDHL PE=2 SV=3 
99 115474 4 
     
SPOT 07 
    
prot_acc prot_desc score mass matches 
ALDOA_HUMAN Fructose-bisphosphate aldolase A OS=Homo sapiens GN=ALDOA PE=1 SV=2 611 39964 39 
PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 457 45083 33 
THIL_HUMAN 
Acetyl-CoA acetyltransferase, mitochondrial OS=Homo sapiens GN=ACAT1 
PE=1 SV=1 
359 45526 15 
AATM_HUMAN 
Aspartate aminotransferase, mitochondrial OS=Homo sapiens GN=GOT2 PE=1 
SV=2 
215 47943 10 
PCBP1_BOVIN Poly(rC)-binding protein 1 OS=Bos taurus GN=PCBP1 PE=2 SV=1 206 38113 7 
HNRPD_HUMAN 
Heterogeneous nuclear ribonucleoprotein D0 OS=Homo sapiens GN=HNRNPD 
PE=1 SV=1 
140 38623 7 
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CSK21_BOVIN Casein kinase II subunit alpha OS=Bos taurus GN=CSNK2A1 PE=1 SV=1 129 45257 7 
SEPT9_HUMAN Septin-9 OS=Homo sapiens GN=SEPT9 PE=1 SV=2 112 65716 6 
DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sapiens GN=SORD PE=1 SV=4 104 39081 6 
TRYP_PIG Trypsin OS=Sus scrofa PE=1 SV=1 96 25246 9 
AATC_HUMAN 
Aspartate aminotransferase, cytoplasmic OS=Homo sapiens GN=GOT1 PE=1 
SV=3 
95 46503 3 
SERC_HUMAN Phosphoserine aminotransferase OS=Homo sapiens GN=PSAT1 PE=1 SV=2 95 40894 3 
RM37_HUMAN 
39S ribosomal protein L37, mitochondrial OS=Homo sapiens GN=MRPL37 PE=1 
SV=2 
84 48726 2 
EF1A1_BOVIN Elongation factor 1-alpha 1 OS=Bos taurus GN=EEF1A1 PE=2 SV=1 84 50535 3 
K1C10_CANFA Keratin, type I cytoskeletal 10 OS=Canis familiaris GN=KRT10 PE=2 SV=1 72 57889 2 
TOM40_BOVIN 
Mitochondrial import receptor subunit TOM40 homolog OS=Bos taurus 
GN=TOMM40 PE=2 SV=1 
60 38127 3 
PRS10_BOVIN 26S protease regulatory subunit 10B OS=Bos taurus GN=PSMC6 PE=2 SV=1 58 44401 2 
     
SPOT 08 
    
prot_acc prot_desc score mass matches 
PDIA3_CERAE 
Protein disulfide-isomerase A3 OS=Cercopithecus aethiops GN=PDIA3 PE=2 
SV=1 
786 57241 41 
SYHC_HUMAN 
Histidyl-tRNA synthetase, cytoplasmic OS=Homo sapiens GN=HARS PE=1 
SV=2 
735 58085 27 
AINX_HUMAN Alpha-internexin OS=Homo sapiens GN=INA PE=1 SV=2 393 55570 17 
HNRPK_BOVIN 
Heterogeneous nuclear ribonucleoprotein K OS=Bos taurus GN=HNRNPK PE=2 
SV=1 
378 51343 17 
VATB2_BOVIN 
V-type proton ATPase subunit B, brain isoform OS=Bos taurus GN=ATP6V1B2 
PE=1 SV=3 
370 56967 15 
ARP3_BOVIN Actin-related protein 3 OS=Bos taurus GN=ACTR3 PE=1 SV=3 293 47909 15 
PEPD_HUMAN Xaa-Pro dipeptidase OS=Homo sapiens GN=PEPD PE=1 SV=3 256 55507 10 
ODO2_HUMAN 
Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate 
dehydrogenase complex, mitochondrial OS=Homo sapiens GN=DLST PE=1 
SV=3 
239 49125 12 
AL9A1_HUMAN 
4-trimethylaminobutyraldehyde dehydrogenase OS=Homo sapiens 
GN=ALDH9A1 PE=1 SV=3 
235 54904 7 
K2C1_HUMAN Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 185 66212 8 
P20D2_HUMAN 
Peptidase M20 domain-containing protein 2 OS=Homo sapiens GN=PM20D2 
PE=1 SV=2 
159 48172 6 
GOPC_HUMAN 
Golgi-associated PDZ and coiled-coil motif-containing protein OS=Homo sapiens 
GN=GOPC PE=1 SV=1 
147 50986 6 
TRYP_PIG Trypsin OS=Sus scrofa PE=1 SV=1 145 25246 9 
NFM_BOVIN Neurofilament medium polypeptide OS=Bos taurus GN=NEFM PE=1 SV=3 139 103219 7 
S10AB_HUMAN Protein S100-A11 OS=Homo sapiens GN=S100A11 PE=1 SV=2 118 11875 5 
NFM_PIG 
Neurofilament medium polypeptide (Fragment) OS=Sus scrofa GN=NEFM PE=1 
SV=2 
105 52096 5 
FAD1_HUMAN FAD synthase OS=Homo sapiens GN=FLAD1 PE=1 SV=1 100 66148 4 
     
SPOT 09 
    
prot_acc prot_desc score mass matches 
PDIA3_CERAE 
Protein disulfide-isomerase A3 OS=Cercopithecus aethiops GN=PDIA3 PE=2 
SV=1 
1193 57241 98 
HNRPK_BOVIN 
Heterogeneous nuclear ribonucleoprotein K OS=Bos taurus GN=HNRNPK PE=2 
SV=1 
521 51343 30 
SNX4_HUMAN Sorting nexin-4 OS=Homo sapiens GN=SNX4 PE=1 SV=1 266 52231 10 
PEPD_HUMAN Xaa-Pro dipeptidase OS=Homo sapiens GN=PEPD PE=1 SV=3 259 55507 10 
LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 238 36970 10 
GOPC_HUMAN 
Golgi-associated PDZ and coiled-coil motif-containing protein OS=Homo sapiens 
GN=GOPC PE=1 SV=1 
237 50986 10 
K2C1_HUMAN Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 200 66212 8 
MSTO1_HUMAN Protein misato homolog 1 OS=Homo sapiens GN=MSTO1 PE=1 SV=1 190 62933 7 
PP2BA_BOVIN 
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform OS=Bos 
taurus GN=PPP3CA PE=1 SV=1 
178 59487 7 
DPYL2_HUMAN 
Dihydropyrimidinase-related protein 2 OS=Homo sapiens GN=DPYSL2 PE=1 
SV=1 
168 62823 6 
GPKOW_HUMAN 
G patch domain and KOW motifs-containing protein OS=Homo sapiens 
GN=GPKOW PE=1 SV=2 
130 52481 5 
TRYP_PIG Trypsin OS=Sus scrofa PE=1 SV=1 122 25246 11 
K22E_HUMAN 
Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 
SV=2 
95 65748 3 
PRS4_HUMAN 26S protease regulatory subunit 4 OS=Homo sapiens GN=PSMC1 PE=1 SV=1 54 49367 2 
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S4. Expression and purification of recombinant 
human LSD1 
 
 
Theorical MW (Protparam prediction): 94 KDa (observed by SDSPAGE 
≈120KDa) 
Theorical pI: 6.0 
 
LSD1 purification is reported in the figure 45, furthermore the induction 
and the purification by His-trap GE column is observable. 
 
Fig. 45 Purification of LSD1 
 
In this coomassie stained SDS-PAGE, they are reported the first step of the purification. The white 
arrows show the intermediate of purification of LSD1. The input represents the extracted proteins, 
sonicated and centrifugated loaded in the column (lane 1 starting from left), while the other lanes are 
the fractions obtained by His trap GE column.  
 
 
 
 
 
 
 
 
 
The fractions 2-8 have been loaded in the G200 superdex 26/60 a size 
                   Input      Fz.2      Fz.3         Fz.4     Fz.5       Fz.6        Fz.7     Fz.8        Fz.9       
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exclusion chromatographic column to separate LSD1 from other 
undesirable proteins. In the figure 46 is reported the final fractionation of 
LSD1.  
 
Fig. 46  Purification of LSD1 
In these two coomassie stained SDS-PAGEs, there are the fraction obtained by the gel-exclusion. The 
white arrows show final result of the purification of LSD1; a single band has been obtained. 
 
 
 
 
The fractions 68-84 have been concentrated by Amicon membrane (Cut-
off 10 KDa. 
1 ml of recombinant LSD1 at concentration 0.9 mg/ml has been 
obtained. 
 
S.5 Phosphorylation of CK2α by Proline directed 
Kinases 
 
In our hypothesis, the phosphorylation of CK2 by Cdk1 starts the pathway; in this section 
we disclose that also other kinases are able to phosphorylate the C-terminus CK2α.    
In the image (Fig.47), we provide evidence about the phosphorylation in the C-terminal 
segment of CK2α-wt (AA 336-391) and also in the N-terminal kinase domain (AA 1-336) 
by Homeodomain Interacting Protein-Kinase 2 (HIPK2), a proline directed kinase. 
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Furthermore the experiment discloses the opposite reaction, the phosphorylation of 
HIPK2 by CK2. 
CK2α-Δ1-336 a C-terminal truncated form of CK2α appears as a bad substrate in 
comparison to CK2α-wt, suggesting that the bigger amount of phosphates are linked to 
the C-terminal domain of the full length protein (Fig. 47).  
Hence, HIPK2 is able to phosphorylate CK2α, as well as, Cdk1.  
The phosphorylation of CK2α by HIPK2 suggests the "activation" of CK2α in the whole 
cell cycle, while Cdk1 is activated only during the early mitosis.  
HIPK2 is activated during the apoptosis [87], and now CK2 might be correlated to the 
DNA condensation in the peculiar half-moon appearance during the early stages of the 
apoptosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
PhosphorImager (Autoradiography) 
 
1                 2                 3                  4  
HIPK2 
 
CK2α forms 
 
: HIPK2 phosphorylation by CK2 
HIPK2 
  
HIPK2 
+ 
CK2α Δ1-336 
HIPK2 
+ 
CK2α Δ1-336 
K68R 
(no catalytic 
activity) 
HIPK2 
+ 
CK2α wt 
Fig. 47: C-terminal phosphorylation of CK2α by HIPK2 
 
In this autoradiography are reported the phosphorylation of HIPK2 by CK2α (lane 3 
vs.lane4) and the phosphorylation of CK2α by HIPK2.  CK2α-Δ1-336 a C-terminal 
truncated form of CK2α appears as a bad substrate in comparison to CK2α-wt; the 
N-terminal section 1-336 is phosphorylated by HIPK2, but the bigger amount of 
phosphates are linked to the C-terminal domain of the full length protein (lane 2 
vs.lane 4). 
 
: Phosphorylation of CK2α by HIPK2 
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